Document:

Exhibit 10.1

 

EXCHANGE
AGREEMENT

 

THIS
EXCHANGE AGREEMENT (the “Agreement”) is dated this 3rd day of June 2022, by and among VNUE, Inc., a Nevada corporation
(the “Company”), and GHS Investments, LLC (the “Holder”), the Holder of those certain Convertible Promissory
Notes dated February 16, 2021 and June 3, 2022, respectively, issued by the Company (the “Notes”) as attached to
Exhibit A below.

 

WHEREAS,
the Holder beneficially owns and holds the Notes; and

 

WHEREAS,
the Holder desire to exchange the entire Principal and all accrued but unpaid Interest owing on the Notes, which the parties agree totals
$268,119 ($182,270 and $85,849, respectively as of June 3, 2022), into 266 shares of the Company’s Series B Preferred Stock
(the “Preferred Stock”) and the Company desires to issue the Preferred Stock in exchange for the Notes, all on the terms
and conditions set forth in this Agreement in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities
Act of 1933, as amended (the “Securities Act”). The $85,849 Note was issued and owing by the Company in connection
with a Securities Purchase Agreement dated July 9, 2021 as a commitment obligation.

 

NOW,
THEREFORE, in consideration of the terms and conditions contained herein, and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the Company and the Holder hereby agree as follows:

 

Section 1.
Exchange. Subject to and upon the terms and conditions set forth in this Agreement, the Holder agrees to surrender to the Company
the Notes and, in exchange therefore, the Company shall issue to the Holder the Preferred Stock.

 

1.1
Closing. On the Closing Date (as defined below), the Company will issue and deliver (or cause to be issued and delivered) the
Preferred Stock to the Holder, or in the name of a custodian or nominee of the Holder, or as otherwise requested by the Holder in writing,
and the Holder will surrender to the Company the Notes. The closing of the Exchange shall occur on June 3, 2022, or as soon thereafter
as the parties may mutually agree in writing (the “Closing Date”), subject to the provisions of Section 4
and Section 5 herein.

 

1.2
Section 3(a)(9). Assuming the accuracy of the representations and warranties of each of the Company and the Holder set forth
in Sections 2 and 3 of this Agreement, the parties acknowledge and agree that the purpose of such representations and warranties
is, among other things, to ensure that the Exchange qualifies as an exchange of securities under Section 3(a)(9) of the Securities
Act.

 

     

     

    

 

Section 2.
Representations and Warranties of the Company. The Company represents and warrants to the Holder that:

 

2.1
Organization and Qualification. The Company and each of the subsidiaries of the Company (the “Subsidiaries”)
is an entity duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its
incorporation or organization, with the requisite power and authority to own and use its properties and assets and to carry on its business
as currently conducted. Neither the Company, nor any Subsidiary is in violation or default of any of the provisions of its respective
certificate or articles of incorporation, bylaws or other organizational or charter documents. Each of the Company and the Subsidiaries
is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which
the nature of the business conducted or property owned by it makes such qualification necessary, except where the failure to be so qualified
or in good standing, as the case may be, could not have or reasonably be expected to result in: (i) a material adverse effect on the
legality, validity or enforceability of this Agreement or any documents executed in connection herewith (the “Transaction Documents”),
(ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial or otherwise) of the
Company and the Subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s ability to perform in any material
respect on a timely basis its obligations under any Transaction Document (any of (i), (ii) or (iii), a “Material Adverse Effect”)
and no proceeding has been instituted in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail
such power and authority or qualification.

 

2.2
Authorization; Enforcement. The Company has the requisite corporate power and authority to enter into and to consummate the transactions
contemplated by this Agreement and each of the other Transaction Documents and otherwise to carry out its obligations hereunder and thereunder.
The execution and delivery of this Agreement and each of the other Transaction Documents by the Company and the consummation by it of
the transactions contemplated hereby and thereby have been duly authorized by all necessary action on the part of the Company and no
further action is required by the Company, the Board of Directors or the Company’s stockholder in connection herewith or therewith
other than in connection with the Required Approvals (as defined below). This Agreement and each other Transaction Document to which
it is a party has been (or upon delivery will have been) duly executed by the Company and, when delivered in accordance with the terms
hereof and thereof, will constitute the valid and binding obligation of the Company enforceable against the Company in accordance with
its terms, except: (i) as limited by general equitable principles and applicable bankruptcy, insolvency, reorganization, moratorium and
other laws of general application affecting enforcement of creditors’ rights generally; (ii) as limited by laws relating to the
availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution
provisions may be limited by applicable law.

 

    2

     

    

 

2.3
Issuance of Preferred Stock. The issuance of the Preferred Stock is duly authorized and, upon issuance in accordance with the
terms hereof, the Preferred Stock shall be validly issued, fully paid and non-assessable. The shares of common stock, par value $0.0001
per share (the “Common Stock”) issued upon conversion of the Preferred Stock, when issued and delivered in accordance
with the terms of the Preferred Stock, will be duly and validly issued, fully paid and non-assessable, free and clear of all Liens (as
defined below) imposed by the Company, other than restrictions on transfer under applicable state and federal securities laws. Upon issuance
in accordance herewith, the issuance by the Company of the Preferred Stock shall be exempt from the registration requirements of the
Securities Act by virtue of Section 3(a)(9) thereunder and all of the shares of Common Stock issuable upon conversion of the Preferred
Stock shall be transferable and tradable by the Holder pursuant to the terms and conditions set forth in the Preferred Stock. The Company
has or will, within 30 calendar days from the execution of this Agreement, reserve from its duly authorized capital stock a number of
shares of Common Stock for issuance of the shares underlying the Preferred Stock equal to 300% of the Required Minimum on the date hereof.
“Required Minimum” means, as of any date, the maximum aggregate number of shares of Common Stock then issued or potentially
issuable in the future pursuant to the Transaction Documents, including any shares of Common Stock issuable upon conversion in full of
all Preferred Stock, ignoring any conversion limits set forth therein, and assuming that the conversion price of the Preferred Stock
is at all times on and after the date of determination the minimum price per share required for either the Company or a Subsidiary to
up-list its common stock onto a national stock exchange.

 

2.4
No Conflicts. The execution, delivery and performance by the Company of this Agreement and the other Transaction Documents to
which it is a party, the issuance of the Preferred Stock and the consummation by it of the transactions contemplated hereby and thereby
do not and will not: (i) conflict with or violate any provision of the Company’s or any Subsidiary’s certificate or articles
of incorporation, bylaws or other organizational or charter documents; (ii) conflict with, or constitute a default (or an event that
with notice or lapse of time or both would become a default) under, result in the creation of any options, contracts, agreements, liens,
security interests, or other encumbrances (“Liens”) upon any of the properties or assets of the Company or any Subsidiary,
or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both)
of, any agreement, credit facility, debt or other instrument (evidencing a Company or Subsidiary debt or otherwise) or other understanding
to which the Company or any Subsidiary is a party or by which any property or asset of the Company or any Subsidiary is bound or affected;
or (iii) subject to the Required Approvals (as defined herein), conflict with or result in a violation of any law, rule, regulation,
order, judgment, injunction, decree or other restriction of any court or governmental authority to which the Company or a Subsidiary
is subject (including federal and state securities laws and regulations), or by which any property or asset of the Company or a Subsidiary
is bound or affected; except in the case of each of clauses (ii) and (iii), such as could not have or reasonably be expected to result
in a Material Adverse Effect.

 

2.5
Acknowledgment Regarding the Exchange. The Company acknowledges and agrees that each Holder is acting solely in the capacity of
an arm’s length third party with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges
no Holder is acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and
the transactions contemplated hereby, and any advice given by any Holder or any of their representatives or agents in connection with
this Agreement is merely incidental to the Exchange.

 

    3

     

    

 

2.6
No Commission; No Other Consideration. The Company has not paid or given, and has not agreed to pay or give, directly or indirectly,
any commission or other remuneration for soliciting the Exchange. The Preferred Stock, and any Common Stock issuable upon conversion
of the Preferred Stock, are being issued exclusively for the exchange of the Notes and no other consideration has or will be paid for
the Preferred Stock or the Common Stock underlying such Preferred Stock.

 

2.7
3(a)(9) Representation. Aside from the Holder, the Company has not, nor has any person acting on its behalf, directly or indirectly
made any offers or sales of any security or solicited any offers to buy any security under circumstances that would cause the Exchange
and the issuance of the Preferred Stock pursuant to this Agreement to be integrated with prior offerings by the Company for purposes
of the Securities Act which would prevent the Company from delivering the Preferred Stock to the Holder pursuant to Section 3(a)(9)
of the Securities Act, nor will the Company take any action or steps that would cause the Exchange, issuance and delivery of the Preferred
Stock to be integrated with other offerings to the effect that the delivery of the Preferred Stock to the Holder would be seen not to
be exempt pursuant to Section 3(a)(9) of the Securities Act.

 

2.8
No Third-party Advisors. None.

 

2.9
SEC Reports; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by the Company under the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
including pursuant to Section 13(a) or 15(d) of the Exchange Act, for the two (2) years preceding the date hereof (or such shorter
period as the Company was required by law or regulation to file such material) (the foregoing materials, including the exhibits thereto
and documents incorporated by reference therein, being collectively referred to herein as the “SEC Reports”) on a
timely basis or has received a valid extension of such time of filing and has filed any such SEC Reports prior to the expiration of any
such extension. As of their respective dates, the SEC Reports complied in all material respects with the requirements of the Securities
Act and the Exchange Act, as applicable, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or
omitted to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of
the circumstances under which they were made, not misleading. The financial statements of the Company included in the SEC Reports comply
in all material respects with applicable accounting requirements and the rules and regulations of the SEC with respect thereto as in
effect at the time of filing. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles applied on a consistent basis during the periods involved (“GAAP”), except as may be otherwise specified
in such financial statements or the Notes thereto and except that unaudited financial statements may not contain all footnotes required
by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated Subsidiaries as of and
for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements,
to normal, immaterial, year-end audit adjustments.

 

    4

     

    

 

2.10
Subsidiaries. All of the direct and indirect Subsidiaries of the Company are set forth on Schedule 2.10. The Company
owns, directly or indirectly, all of the capital stock or other equity interests of each Subsidiary free and clear of any Liens, and
all of the issued and outstanding shares of capital stock of each Subsidiary are validly issued and are fully paid, non-assessable and
free of preemptive and similar rights to subscribe for or purchase securities.

 

2.11
Filings, Consents and Approvals. Other than as set forth on Schedule 2.11, the Company is not required to obtain any
consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority or any natural person, firm, partnership, association, corporation, company, trust, business
trust or other entity (each, a “Person”) in connection with the execution, delivery and performance by the Company
of the Transaction Documents, other than the notice and/or application(s) to each applicable Trading Market (as defined herein) for the
issuance and the listing of the shares of Common Stock issuable upon conversion of the Preferred Stock for trading thereon in the time
and manner required thereby (collectively, the “Required Approvals”).

 

2.12
Capitalization. The capitalization of the Company is as set forth on Schedule 2.12. No Person has any right of first
refusal, preemptive right, right of participation, or any similar right to participate in the transactions contemplated by the Transaction
Documents. Other than as set forth on Schedule 2.12, there are no outstanding options, warrants, scrip rights to subscribe
to, calls or commitments of any character whatsoever relating to, or securities, rights or obligations convertible into or exercisable
or exchangeable for, variable-rate instruments, anti-dilutive securities, or any other security that would or giving any Person any right
to subscribe for or acquire any shares of Common Stock, or contracts, commitments, understandings or arrangements by which the Company
or any Subsidiary is or may become bound to issue additional shares of Common Stock or any securities of the Company which would entitle
the holder thereof to acquire at any time Common Stock, including, without limitation, any debt, preferred stock, right, option, warrant
or other instrument that is at any time convertible into or exercisable or exchangeable for, or otherwise entitles the holder thereof
to receive, Common Stock. All of the outstanding shares of capital stock of the Company are duly authorized, validly issued, fully paid
and nonassessable, have been issued in compliance with all federal and state securities laws, and none of such outstanding shares was
issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization
of any stockholder, the Board of Directors or others is required for the issuance of the Preferred Stock. There are no stockholder agreements
or other similar agreements with respect to the Company’s capital stock to which the Company is a party or, to the knowledge of
the Company, between or among any of the Company’s stockholders.

 

    5

     

    

 

2.13
DTC Eligibility. The Company, through the Transfer Agent, currently participates in the
DTC Fast Automated Securities Transfer (FAST) Program and the Common Stock can be transferred electronically to third parties via the
DTC Fast Automated Securities Transfer (FAST) Program.

 

2.14
Material Changes; Undisclosed Events, Liabilities or Developments. Except as set forth in Schedule 2.14 or in a subsequent
SEC Report filed prior to the date hereof, since the date of the latest audited financial statements included within the SEC Reports:
(i) there has been no event, occurrence or development that has had or that could reasonably be expected to result in a Material Adverse
Effect; (ii) the Company has not incurred any liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses
incurred in the ordinary course of business consistent with past practice and (B) liabilities not required to be reflected in the Company’s
financial statements pursuant to GAAP or disclosed in filings made with the SEC; (iii) the Company has not altered its method of accounting;
(iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholder or purchased, redeemed
or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued any equity securities
to any officer, director or Affiliate (as defined below), except pursuant to existing Company stock option plans. The Company does not
have pending any request for confidential treatment of information before the SEC. Except for the issuance of the Preferred Stock contemplated
by this Agreement, no event, liability, fact, circumstance, occurrence or development has occurred or exists or is reasonably expected
to occur or exist with respect to the Company or its Subsidiaries or their respective businesses, properties, operations, assets or financial
condition, that would be required to be disclosed by the Company under applicable securities laws at the time this representation is
made or deemed made that has not been publicly disclosed at least one (1) Trading Day (as defined below) prior to the date that this
representation is made.

 

2.15
Litigation. Other than as set forth on Schedule 2.15, there is no action, suit, inquiry, notice of violation, proceeding
or investigation pending or, to the knowledge of the Company, threatened against or affecting the Company, any Subsidiary or any of their
respective properties before or by any court, arbitrator, governmental or administrative agency or regulatory authority (federal, state,
county, local or foreign) (collectively, an “Action”) which (i) adversely affects or challenges the legality, validity
or enforceability of any of the Transaction Documents or the Preferred Stock or (ii) could, if there were an unfavorable decision, have
or reasonably be expected to result in a Material Adverse Effect. Neither the Company nor any Subsidiary, nor any director or officer
thereof, is or has been the subject of any Action involving a claim of violation of or liability under federal or state securities laws
or a claim of breach of fiduciary duty. There has not been, and to the knowledge of the Company, there is not pending or contemplated,
any investigation by the SEC involving the Company or any current or former director or officer of the Company. The SEC has not issued
any stop order or other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under
the Exchange Act or the Securities Act.

 

    6

     

    

 

2.16
Labor Relations. No labor dispute exists or, to the knowledge of the Company, is imminent with respect to any of the employees
of the Company, which could reasonably be expected to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’
employees is a member of a union that relates to such employee’s relationship with the Company or such Subsidiary, and neither
the Company nor any of its Subsidiaries is a party to a collective bargaining agreement, and the Company and its Subsidiaries believe
that their relationships with their employees are good. To the knowledge of the Company, no executive officer of the Company or any Subsidiary,
is, or is now expected to be, in violation of any material term of any employment contract, confidentiality, disclosure or proprietary
information agreement or non-competition agreement, or any other contract or agreement or any restrictive covenant in favor of any third
party, and the continued employment of each such executive officer does not subject the Company or any of its Subsidiaries to any liability
with respect to any of the foregoing matters. The Company and its Subsidiaries are in compliance with all U.S. federal, state, local
and foreign laws and regulations relating to employment and employment practices, terms and conditions of employment and wages and hours,
except where the failure to be in compliance could not, individually or in the aggregate, reasonably be expected to have a Material Adverse
Effect.

 

2.17
Compliance. Other than as set forth on Schedule 2.17, neither the Company nor any Subsidiary: (i) is in default under
or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a
default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received notice of a claim that it is in default
under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party
or by which it or any of its properties is bound (whether or not such default or violation has been waived); (ii) is in violation of
any judgment, decree or order of any court, arbitrator or other governmental authority or (iii) is or has been in violation of any statute,
rule, ordinance or regulation of any governmental authority, including without limitation all foreign, federal, state and local laws
relating to taxes, environmental protection, occupational health and safety, product quality and safety and employment and labor matters,
except in each case as could not have or reasonably be expected to result in a Material Adverse Effect.

 

2.18
Regulatory Permits. The Company and the Subsidiaries possess all certificates, authorizations and permits issued by the appropriate
federal, state, local or foreign regulatory authorities necessary to conduct their respective businesses as described in the SEC Reports,
except where the failure to possess such permits could not reasonably be expected to result in a Material Adverse Effect (“Material
Permits”), and neither the Company nor any Subsidiary has received any notice of proceedings relating to the revocation or
modification of any Material Permit.

 

    7

     

    

 

2.19
Title to Assets. The Company and the Subsidiaries have good and marketable title in fee simple to all real property owned by them
and good and marketable title in all personal property owned by them that is material to the business of the Company and the Subsidiaries,
in each case free and clear of all Liens, except for (i) Liens as do not materially affect the value of such property and do not materially
interfere with the use made and proposed to be made of such property by the Company and the Subsidiaries, (ii) Liens for the payment
of federal, state or other taxes, for which appropriate reserves have been made therefor in accordance with GAAP and, the payment of
which is neither delinquent nor subject to penalties and (iii) Liens held by the Holder. Any real property and facilities held under
lease by the Company and the Subsidiaries are held by them under valid, subsisting and enforceable leases with which the Company and
the Subsidiaries are in compliance.

 

2.20
Intellectual Property. Other than as set forth on Schedule 2.20, the Company and the Subsidiaries have, or have rights
to use, all patents, patent applications, trademarks, trademark applications, service marks, trade names, trade secrets, inventions,
copyrights, licenses and other intellectual property rights and similar rights as described in the SEC Reports as necessary or required
for use in connection with their respective businesses and which the failure to so have could have a Material Adverse Effect (collectively,
the “Intellectual Property Rights”). Except as set forth on Schedule 2.20 neither the Company nor any
Subsidiary has received a notice (written or otherwise) that any of, the Intellectual Property Rights has expired, terminated or been
abandoned, or is expected to expire or terminate or be abandoned, within two (2) years from the date of this Agreement. Neither the Company
nor any Subsidiary has received, since the date of the latest audited financial statements included within the SEC Reports, a written
notice of a claim or otherwise has any knowledge that the Intellectual Property Rights violate or infringe upon the rights of any Person,
except as could not have or reasonably be expected to not have a Material Adverse Effect. To the knowledge of the Company, all such Intellectual
Property Rights are enforceable and there is no existing infringement by another Person of any of the Intellectual Property Rights. The
Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their
intellectual properties, except where failure to do so could not, individually or in the aggregate, reasonably be expected to have a
Material Adverse Effect.

 

2.21
Intentionally Omitted.

 

    8

     

    

 

2.22
Transactions With Affiliates and Employees. Other than as set forth in the Company’s SEC Reports, none of the officers or
directors of the Company or any Subsidiary and, to the knowledge of the Company, none of the employees of the Company or any Subsidiary
is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees, officers and directors),
including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental of real
or personal property to or from providing for the borrowing of money from or lending of money to, or otherwise requiring payments to
or from any officer, director or such employee or, to the knowledge of the Company, any entity in which any officer, director, or any
such employee has a substantial interest or is an officer, director, trustee, stockholder, member or partner, in each case in excess
of $120,000 other than for: (i) payment of salary or consulting fees for services rendered, (ii) reimbursement for expenses incurred
on behalf of the Company and (iii) other employee benefits, including stock option agreements under any stock option plan of the Company.

 

2.23
Intentionally Omitted.

 

2.24
Certain Fees. No brokerage or finder’s fees or commissions are or will be payable by the Company or any Subsidiaries to
any broker, financial advisor or consultant, finder, placement agent, investment banker, bank or other Person with respect to the transactions
contemplated by the Transaction Documents.

 

2.25
Investment Company. The Company is not, and is not an Affiliate of, and immediately after the consummation of the transactions
contemplated hereby, will not be or be an Affiliate of, an “investment company” within the meaning of the Investment Company
Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become an “investment company”
subject to registration under the Investment Company Act of 1940, as amended.

 

2.26
Registration Rights. Other than as set forth on Schedule 2.26 and the Transaction Documents, no Person has any right
to cause the Company to effect the registration under the Securities Act of any securities of the Company or any Subsidiaries.

 

2.27
Listing and Maintenance Requirements. Other than as set forth in Schedule 2.27, the Company
has not, in the twelve (12) months preceding the date hereof, received notice from the OTC Markets or any other exchange or quotation
service on which the Common Stock is or has been listed or quoted (the “Trading Market”) to the effect that the Company
is not in compliance with the listing or maintenance requirements of such Trading Market. Other than as set forth in Schedule 2.27,
the Company is, and has no reason to believe that it will not in the foreseeable future continue to be, in compliance with all such listing
and maintenance requirements.

 

    9

     

    

 

2.28
Application of Takeover Protections. The Company and the Board of Directors have taken all necessary action, if any, in order
to render inapplicable any control share acquisition, business combination, poison pill (including any distribution under a rights agreement)
or other similar anti-takeover provision under the Company’s articles of incorporation (or similar charter documents) or the laws
of its state of incorporation that is or could become applicable to the Holder as a result of the Holder and the Company fulfilling their
obligations or exercising their rights under the Transaction Documents, including without limitation as a result of the Company’s
issuance of the Preferred Stock pursuant to the Exchange.

 

2.29
Securities Laws Disclosure; Publicity. The Company shall issue a press release disclosing the material terms of the transactions
contemplated hereby within 5 trading days of the execution of this agreement. From and after the issuance of such press release, the
Company represents to the Holder that it shall have publicly disclosed all material, non-public information delivered to any of the Holder
by the Company or any of its Subsidiaries, or any of their respective officers, directors, employees or agents in connection with the
transactions contemplated by the Transaction Documents. In addition, effective upon the issuance of such press release, the Company acknowledges
and agrees that any and all confidentiality or similar obligations under any agreement, whether written or oral, between the Company,
any of its Subsidiaries or any of their respective officers, directors, agents, employees or Affiliates on the one hand, and any of the
Holder or any of their Affiliates on the other hand, with respect to the transactions contemplated by the Transaction Documents shall
terminate. Notwithstanding the foregoing, the Company shall not publicly disclose the name of any Holder, or include the name of any
Holder in any filing with the Commission or any regulatory agency or Trading Market, without the prior written consent of such Holder,
except to the extent such disclosure is required by law or Trading Market regulations, in which case the Company shall provide the Holder
with prior notice of such disclosure. In addition to the foregoing, after the consummation of the transactions contemplated hereby, the
Company shall publicly disclose the sale of assets of the Company via a press release within four (4) Trading Days after the consummation
of such sale. As used in this Section 2.29 and throughout this Agreement, “Trading Day” means a day on which the Trading
Market is open for trading and “Trading Market” means any of the following markets or exchanges on which the Common Stock
is listed or quoted for trading on the date in question: the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the
Nasdaq Global Select Market, the New York Stock Exchange, the OTCQB, OTCQX, or OTC Pink Sheets (or any successors to any of the foregoing).No
Integrated Offering. Assuming the accuracy of each Holder’s representations and warranties set forth in Section 3, neither
the Company, nor any of its Affiliates, nor any Person acting on their behalf has, directly or indirectly, made any offers or sales of
any security or solicited any offers to buy any security, under circumstances that would cause the Exchange to be integrated with prior
offerings by the Company for purposes of (i) the Securities Act which would require the registration of any such securities under the
Securities Act, or (ii) any applicable shareholder approval provisions of any Trading Market on which any of the securities of the Company
are listed or designated.

 

    10

     

    

 

2.30
Solvency. The Company does not intend to incur debts beyond its ability to pay such debts as they mature (taking into account
the timing and amounts of cash to be payable on or in respect of its debt). Except as set forth in Schedule 2.31, the SEC
Reports set forth as of the date hereof all outstanding secured and unsecured Indebtedness of the Company or any Subsidiary, or for which
the Company or any Subsidiary has commitments. For the purposes of this Agreement, “Indebtedness” means (x) any liabilities
for borrowed money or amounts owed in excess of $50,000 (other than trade accounts payable incurred in the ordinary course of business),
(y) all guaranties, endorsements and other contingent obligations in respect of indebtedness of others, whether or not the same, are,
or should be, reflected in the Company’s consolidated balance sheet (or the Notes thereto), except guaranties by endorsement of
negotiable instruments for deposit or collection or similar transactions in the ordinary course of business; and (z) the present value
of any lease payments in excess of $50,000 due under leases required to be capitalized in accordance with GAAP. Other than as set forth
in Schedule 2.31, neither the Company nor any Subsidiary is in default with respect to any Indebtedness.

 

2.31
Tax Status. Except as set forth in Schedule 2.32 and for matters that would not, individually or in the aggregate,
have or reasonably be expected to result in a Material Adverse Effect, the Company and its Subsidiaries each (i) has made or filed all
United States federal, state and local income and all foreign income and franchise tax returns, reports and declarations required by
any jurisdiction to which it is subject, (ii) has paid all taxes and other governmental assessments and charges that are material in
amount, shown or determined to be due on such returns, reports and declarations and (iii) has set aside on its books provision reasonably
adequate for the payment of all material taxes for periods subsequent to the periods to which such returns, reports or declarations apply.
Except as set forth in Schedule 2.32, there are no unpaid taxes in any material amount claimed to be due by the taxing authority
of any jurisdiction, and the officers of the Company or of any Subsidiary know of no basis for any such claim.

 

2.32
Foreign Corrupt Practices. Neither the Company nor any Subsidiary, nor to the knowledge of the Company or any Subsidiary, any
agent or other person acting on behalf of the Company or any Subsidiary, has: (i) directly or indirectly, used any funds for unlawful
contributions, gifts, entertainment or other unlawful expenses related to foreign or domestic political activity; (ii) made any unlawful
payment to foreign or domestic government officials or employees or to any foreign or domestic political parties or campaigns from corporate
funds; (iii) failed to disclose fully any contribution made by the Company or any Subsidiary (or made by any person acting on its behalf
of which the Company is aware) which is in violation of law or (iv) violated in any material respect any provision of FCPA.

 

2.33
No Disagreements with Accountants and Lawyers. There are no disagreements of any kind presently existing, or reasonably anticipated
by the Company to arise, between the Company and the accountants and lawyers formerly or presently employed by the Company and the Company
is current with respect to any fees owed to its accountants and lawyers which could affect the Company’s ability to perform any
of its obligations under any of the Transaction Documents.

 

    11

     

    

 

2.34
Acknowledgment Regarding Holder’ Exchange of the Preferred Stock. The Company acknowledges and agrees that each Holder is
acting solely in the capacity of an arm’s length party with respect to the Transaction Documents and the transactions contemplated
thereby.

 

2.35 Regulation
M Compliance. The Company has not, and to its knowledge no one acting on its behalf has, (i) taken, directly or indirectly, any action
designed to cause or to result in the stabilization or manipulation of the price of any security of the Company to facilitate the issuance
or resale of any of the Preferred Stock or the shares of Common Stock into which the Preferred Stock are convertible or exercisable,
as applicable, (ii) sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Preferred Stock or the
shares of Common Stock into which the Preferred Stock are convertible or exercisable, as applicable, or (iii) paid or agreed to pay to
any Person any compensation for soliciting another to purchase any other securities of the Company.

 

2.36
Office of Foreign Assets Control. Neither the Company nor any Subsidiary nor, to the Company’s knowledge, any director,
officer, agent, employee or affiliate of the Company or any Subsidiary is currently subject to any U.S. sanctions administered by the
Office of Foreign Assets Control of the U.S. Treasury Department (“OFAC”).

 

2.37
Bank Holding Company Act. Neither the Company nor any of its Subsidiaries or Affiliates is subject to the Bank Holding Company
Act of 1956, as amended (the “BHCA”) and to regulation by the Board of Governors of the Federal Reserve System (the
“Federal Reserve”). Neither the Company nor any of its Subsidiaries or Affiliates owns or controls, directly or indirectly,
five percent (5%) or more of the outstanding shares of any class of voting securities or twenty-five percent (25%) or more of the total
equity of a bank or any entity that is subject to the BHCA and to regulation by the Federal Reserve. Neither the Company nor any of its
Subsidiaries or Affiliates exercises a controlling influence over the management or policies of a bank or any entity that is subject
to the BHCA and to regulation by the Federal Reserve.

 

2.38
Money Laundering. The operations of the Company and its Subsidiaries are and have been conducted at all times in compliance with
applicable financial record-keeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
applicable money laundering statutes and applicable rules and regulations thereunder (collectively, the “Money Laundering Laws”),
and no action, suit or proceeding by or before any court or governmental agency, authority or body or any arbitrator involving the Company
or any Subsidiary with respect to the Money Laundering Laws is pending or, to the knowledge of the Company or any Subsidiary, threatened.

 

    12

     

    

 

 

Section 3.
Representations and Warranties of the Holder. Each Holder hereby severally, and not jointly, represents and warrants to the Company
that:

 

3.1
Ownership of the Preferred Stock. The Holder is the legal and beneficial owner of the Notes. The Holder paid for the Notes,
and has continuously held the Notes since their issuance or purchase. The Holder, individually or through an affiliate, owns the
Notes outright and free and clear of any options, contracts, agreements, liens, security interests, or other encumbrances.

 

3.2
No Public Sale or Distribution. The Holder is acquiring the Preferred Stock in the ordinary course of business for its own account
and not with a view toward, or for resale in connection with, the public sale or distribution thereof; provided, however, that by making
the representations herein and subject to the terms and conditions of the Preferred Stock, the Holder does not agree to hold any of the
Preferred Stock or the shares of Common Stock into which such security is convertible, for any minimum or other specific term and reserves
the right to dispose of the Preferred Stock and the shares of Common Stock into which such security is convertible at any time in accordance
with an exemption from the registration requirements of the Securities Act and applicable state securities laws. The Holder does not
presently have any agreement or understanding, directly or indirectly, with any person to distribute, or transfer any interest or grant
participation rights in, the Preferred Stock or the Notes.

 

3.3
Accredited Investor and Affiliate Status. The Holder is an “accredited investor” as that term is defined in Rule 501
of Regulation D under the Securities Act. The Holder is not, and has not been, for a period of at least three (3) months prior to the
date of this Agreement (a) an officer or director of the Company, (b) an “affiliate” of the Company (as defined in Rule 144)
(an “Affiliate”) or (c) a “beneficial owner” of more than 10% of the Company’s Common Stock (as
defined for purposes of Rule 13d-3 of the Exchange Act).

 

3.4
Reliance on Exemptions. The Holder understands that the Exchange is being made in reliance on specific exemptions from the registration
requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of,
and the Holder’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Holder
set forth herein in order to determine the availability of such exemptions and the eligibility of the Holder to complete the Exchange
and to acquire the Preferred Stock.

 

3.5
Information. The Holder has been furnished with all materials relating to the business, finances and operations of the Company
and materials relating to the Exchange which have been requested by the Holder. The Holder has been afforded the opportunity to ask questions
of the Company. Neither such inquiries nor any other due diligence investigations conducted by the Holder or its representatives shall
modify, amend or affect the Holder’s right to rely on the Company’s representations and warranties contained herein. The
Holder acknowledges that all of the documents filed by the Company with the SEC under Sections 13(a), 14(a) or 15(d) of the Exchange
Act that have been posted on the SEC’s EDGAR site are available to the Holder, and the Holder has not relied on any statement of
the Company not contained in such documents in connection with the Holder’s decision to enter into this Agreement and the Exchange.

 

    13

     

    

 

3.6
Risk. The Holder understands that its investment in the Preferred Stock involves a high degree of risk. The Holder is able to
bear the risk of an investment in the Preferred Stock including, without limitation, the risk of total loss of its investment. The Holder
has sought such accounting, legal and tax advice as it has considered necessary to make an informed investment decision with respect
to the Exchange. There is no assurance that the Preferred Stock or any securities into which the Preferred Stock may convert will continue
to be quoted, traded or listed for trading or quotation on the OTC Markets or on any other organized market or quotation system.

 

3.7
No Governmental Review. The Holder understands that no United States federal or state agency or any other government or governmental
agency has passed on or made any recommendation or endorsement in connection with the Exchange or the fairness or suitability of the
investment in the Preferred Stock nor have such authorities passed upon or endorsed the merits of the Preferred Stock.

 

3.8
Organization; Authorization. The Holder is duly organized, validly existing and in good standing under the laws of its state of
formation and has the requisite organizational power and authority to enter into and perform its obligations under this Agreement.

 

3.9
Validity; Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Holder and
shall constitute the legal, valid and binding obligations of the Holder enforceable against the Holder in accordance with its terms.
The execution, delivery and performance of this Agreement by the Holder and the consummation by the Holder of the transactions contemplated
hereby (including, without limitation, the irrevocable surrender of the Preferred Stock) will not result in a violation of the organizational
documents of the Holder.

 

3.10
Prior Investment Experience. The Holder acknowledges that it has prior investment experience, including investment in securities
of the type being exchanged, including the Preferred Stock and the Preferred Stock, and has read all of the documents furnished or made
available by the Company to it and is able to evaluate the merits and risks of such an investment on its behalf, and that it recognizes
the highly speculative nature of this investment.

 

3.11
Tax Consequences. The Holder acknowledges that the Company has made no representation regarding the potential or actual tax consequences
for the Holder which will result from entering into the Agreement and from consummation of the Exchange. The Holder acknowledges that
it bears complete responsibility for obtaining adequate tax advice regarding the Agreement and the Exchange.

 

3.12
No Registration, Review or Approval. The Holder acknowledges, understands and agrees that the Preferred Stock is being exchanged
hereunder pursuant to an exchange offer exemption under Section 3(a)(9) of the Securities Act.

 

    14

     

    

 

Section 4.
Conditions Precedent to Obligations of the Company. The obligation of the Company to consummate the transactions contemplated
by this Agreement is subject to the satisfaction of each of the following conditions, provided that these conditions are for the Company’s
sole benefit and may be waived by the Company at any time in its sole discretion by providing the Holder with prior written notice thereof:

 

4.1
Delivery. The Holder shall have delivered to the Company the Notes;

 

4.2
No Prohibition. No order of any court, arbitrator, or governmental or regulatory authority shall be in effect which purports to
enjoin or restrain any of the transactions contemplated by this Agreement;

 

4.3
Representations. The accuracy in all material respects when made and on the applicable Closing Date of the representations and
warranties of the Holder contained herein (unless as of a specific date therein); and

 

4.4
Intentionally Omitted.

 

Section 5.
Conditions Precedent to Obligations of the Holder. The obligation of the Holder to consummate the transactions contemplated by
this Agreement is subject to the satisfaction of each of the following conditions, provided that these conditions are for the Holder’s
sole benefit and may be waived by the Holder at any time in its sole discretion by providing the Company with prior written notice thereof:

 

5.1
No order of any court, arbitrator, or governmental or regulatory authority shall be in effect which purports to enjoin or restrain any
of the transactions contemplated by this Agreement;

 

5.2
the representations and warranties of the Company (i) shall be true and correct in all material respects when made and on the applicable
Closing Date (unless as of a specific date therein) for such representations and warranties contained herein that are not qualified by
“materiality” or “Material Adverse Effect” and (ii) shall be true and correct when made and on the applicable
Closing Date (unless as of specific date therein) for such representations and warranties contained herein that are qualified by “materiality”
or “Material Adverse Effect”;

 

5.3
all obligations, covenants and agreements of the Company required to be performed at or prior to the applicable Closing Date shall have
been performed; and

 

    15

     

    

 

5.4
from the date hereof to the relevant Closing Date, trading in the Company’s common stock shall not have been suspended by the SEC
or any Trading Market and, at any time prior to the Closing Date, trading in securities generally as reported by Bloomberg L.P. shall
not have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such
service, or on any trading market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such
magnitude in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of
the Holder makes it impracticable or inadvisable to purchase the Preferred Stock at the closing; and

 

Section 6.
Holding Period. For the purposes of Rule 144 of the Securities Act, the Company acknowledges that the holding period of the
Preferred Stock may be tacked on the holding period of the Notes, and the Company agrees not to a position contrary to this Section 6.

 

Section 7.
Arbitration. Any dispute, controversy or claim arising directly or indirectly from or in connection with this Agreement shall
be resolved by binding arbitration and shall be construed under the laws of the state of New York.

 

Section 8.
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the
same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party; provided
that an electronic signature shall be considered due execution and shall be binding upon the signatory thereto with the same force and
effect as if the signature were an original, not an electronic signature.

 

Section 9.
Headings. The headings of this Agreement are for convenience of reference and shall not form part of, or affect the interpretation
of, this Agreement.

 

Section 10.
Severability. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.

 

Section 11.
No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

Section 12.
Entire Agreement; Amendments. This Agreement supersedes all other prior oral or written agreements between the Holder, the Company,
their affiliates and persons acting on their behalf with respect to the matters discussed herein, and this Agreement and the instruments
referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except
as specifically set forth herein or therein, neither the Company nor the Holder make any representation, warranty, covenant or undertaking
with respect to such matters. No provision of this Agreement may be amended other than by an instrument in writing signed by the Company
and the Holder. No provision hereof may be waived other than by an instrument in writing signed by the party against whom enforcement
is sought.

 

    16

     

    

 

Section 13.
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement
must be in writing and will be deemed to have been delivered: (a) upon receipt, when delivered personally; (b) upon receipt, when sent
by electronic mail (provided confirmation of transmission is mechanically or electronically generated and kept on file by the sending
party); or (c) one (1) calendar day (excluding Saturdays, Sundays, and national banking holidays) after deposit with an overnight courier
service, in each case properly addressed to the party to receive the same.

 

The
addresses and e-mail addresses for such communications shall be:

 

	 	If to the Company:	 	VNUE, Inc.
	 		 	104 W. 29th 11th
    Floor, NY, NY 10001
	 	Attn:	 	Zach Bair
	 	Email:	 	zach.bair@vnue.com

 

If
to the Holder, to the Holder’s address indicated on the signature page of this Agreement or to such other address and/or e-mail
address and/or to the attention of such other person as the recipient party has specified by written notice given to each other party
five (5) days prior to the effectiveness of such change.

 

Section 14.
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective successors
and assigns, including any purchasers of the Preferred Stock. The Holder may assign some or all of its rights hereunder without the consent
of the Company, in which event such assignee shall be deemed to be the Holder hereunder with respect to such assigned rights.

 

Section 15.
No Third Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted
successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

Section 16.
Survival of Representations. The representations and warranties of the Company and the Holder contained in Sections 2 and
3, respectively, will survive the closing of the transactions contemplated by this Agreement.

 

Section 17.
Further Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as any other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

Section 18.
Holder’s Obligations. The obligations of each Holder under any Transaction Document are several and not joint with the obligations
of any other Holder, and no Holder shall be responsible in any way for the performance or non-performance of the obligations of any other
Holder under any Transaction Document.

 

[Signature
Page Follows]

 

    17

     

    

 

IN
WITNESS WHEREOF, the parties have executed this Exchange Agreement as of the date first written above.

 

VNUE,
INC.

 

	By:	 	 
	Name:	 	 
	Title:	 	 

 

GHS
Investments, LLC

 

	By:	 	 
	Name:	 	 
	Title:	 	 
	Address:	 	 
	Email:	 	 

 

    18

     

    

 

SCHEDULES

 

Disclosure
Schedules to Exchange Agreement between VNUE, Inc. and the Holder dated June 3, 2022.

 

Schedule 2.12

 

As
of the date hereof, VNUE, Inc., a Nevada corporation, has the following capitalization: (i) 2,000,000,000 shares of Common Stock, par
value $0.0001 per share, and (ii) 20,000,000 shares of Preferred Stock, par value $0.0001 per share, of which 5,000,000 shares are designated
as Series A Convertible Preferred Stock, 2,500 are designated as Series B Preferred Stock and 10,000 are designated as Series C Preferred
Stock. As of the date hereof, (i) 1,462,294,289 shares of Common Stock are issued and outstanding, all of which are duly authorized,
validly issued, fully paid and non-assessable, (ii) 4,250,579 shares of Series A Stock are issued and outstanding, all of which are duly
authorized, validly issued, fully paid and non-assessable, (iii) 1,535 shares of Series B Preferred Stock are issued and outstanding
all of which are duly authorized, validly issued, fully paid and non-assessable; (iv) 3,000 shares of Series C Preferred Stock are issued
and outstanding all of which are duly authorized, validly issued, fully paid and non-assessable; and (v) 588,232,876 shares of Common
Stock are reserved for future issuances.

 

2.15
Litigation

 

Litigation

 

Golock
Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments,
LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the
United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is
in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW, and
seeks declaratory judgment, injunctive relief, and specific performance against the Company.

 

On
December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the
initial complaint, and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with
affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiffs claims
are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange
Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief
from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the
convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New
York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws.

 

EXHIBIT
A- Notes

 

    19Exhibit
10.2

 

EQUITY
FINANCING AGREEMENT

 

This
EQUITY FINANCING AGREEMENT (the “Agreement”), dated as of June 6, 2022 (the “Execution Date”), is entered
into by and between VNUE, Inc., a Nevada corporation with its principal executive office at 104 West 29th Street, 11th
Floor, New York, NY 10001 (the “Company”), and GHS Investments LLC, a Nevada limited liability company, with
offices at 420 Jericho Turnpike, Suite 102, Jericho, NY 11753 (the “Investor”). 

 

RECITALS:

 

WHEREAS,
the parties desire that, upon the terms and subject to the conditions contained herein, the Investor shall invest up to Ten Million Dollars
($10,000,000) (the “Commitment Amount”), over the course of twenty four (24) months immediately following the Effective Date
(the “Contract Period”) to purchase the Company’s common stock, par value $0.0001 per share (the “Common Stock”);

 

WHEREAS,
such investments will be made in reliance upon the exemption from securities registration afforded by Section 4(a)(2) of the Securities
Act of 1933, as amended (the “1933 Act”), Rule 506 of Regulation D promulgated by the SEC under the 1933 Act,
and/or upon such other exemption from the registration requirements of the 1933 Act as may be available with respect to any or all of
the investments in Common Stock to be made hereunder; and

 

WHEREAS,
contemporaneously with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration Rights
Agreement substantially in the form attached hereto as Exhibit A (the “Registration Rights Agreement”) pursuant
to which the Company has agreed to provide certain registration rights under the 1933 Act, and the rules and regulations promulgated
thereunder, and applicable state securities laws.

 

NOW
THEREFORE, in consideration of the foregoing recitals, which shall be considered an integral part of this Agreement, the covenants and
agreements set forth hereafter, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged,
the Company and the Investor hereby agree as follows:

 

SECTION
I.

DEFINITIONS

 

For
all purposes of and under this Agreement, the following terms shall have the respective meanings below, and such meanings shall be equally
applicable to the singular and plural forms of such defined terms.

 

“1933
Act” shall have the meaning set forth in the recitals.

 

“1934
Act” shall mean the Securities Exchange Act of 1934, as amended, or any similar federal statute, and the rules and regulations
of the SEC thereunder, all as the same will then be in effect.

 

“Affiliate”
shall have the meaning set forth in Section 5.7.

 

“Agreement”
shall have the meaning set forth in the preamble.

 

“Articles
of Incorporation” shall have the meaning set forth in Section 4.3.

 

     

     

    

 

“By-laws”
shall have the meaning set forth in Section 4.3.

 

“Closing”
shall have the meaning set forth in Section 2.4.

 

“Closing
Date” shall have the meaning set forth in Section 2.4.

 

“Common
Stock” shall have the meaning set forth in the recitals.

 

“Control”
or “Controls” shall have the meaning set forth in Section 5.7.

 

“Effective
Date” shall mean the date the SEC declares effective under the 1933 Act the Registration Statement covering the Securities.

 

“Environmental
Laws” shall have the meaning set forth in Section 4.13.

 

“Equity
Incentive” shall have the meaning set forth in Section 2.7.

 

“Execution
Date” shall have the meaning set forth in the preamble.

 

“Indemnified
Liabilities” shall have the meaning set forth in Section 10.

 

“Indemnitees”
shall have the meaning set forth in Section 10.

 

“Indemnitor”
shall have the meaning set forth in Section 10.

 

“Ineffective
Period” shall mean any period of time that the Registration Statement or any supplemental registration statement becomes ineffective
or unavailable for use for the sale or resale, as applicable, of any or all of the Registrable Securities (as defined in the Registration
Rights Agreement) for any reason (or in the event the prospectus under either of the above is not current and deliverable) during any
time period required under the Registration Rights Agreement.

 

“Investor”
shall have the meaning set forth in the preamble.

 

“Market
Price” shall mean the lowest daily volume weighted average price (“VWAP”) of the Common Stock during the Pricing
Period.

 

“Material
Adverse Effect” shall have the meaning set forth in Section 4.1.

 

“Maximum
Common Stock Issuance” shall have the meaning set forth in Section 2.5.

 

“Open
Period” shall mean the period beginning on and including the Trading Day immediately following the Effective Date and ending
on the termination of the Agreement in accordance with Section 8.

 

“Pricing
Period” shall mean the ten (10) consecutive Trading Days preceding the relevant Put Notice Date.

 

“Principal
Market” shall mean the New York Stock Exchange, the NYSE American, the Nasdaq Capital Market, the Nasdaq Global Market, the
Nasdaq Global Select Market or the OTC Markets, whichever is the principal market on which the Common Stock is listed.

 

    2

     

    

 

“Prospectus”
shall mean the prospectus, preliminary prospectus and supplemental prospectus used in connection with the Registration Statement.

 

“Purchase
Amount” shall mean the total amount being paid by the Investor on a particular Closing Date to purchase the Securities.

 

“Purchase
Price” shall mean eighty percent (80%) of the Market Price. Following an up-list to the NASDAQ or an equivalent national exchange
by the Company, the Purchase price shall mean ninety percent (90%) of the Market Price, subject to a floor of $0.0001 per share, below
which the Company shall not deliver a Put.

 

“Put”
shall mean the Company is entitled to request equity investments (the “Put” or “Puts”) by the Investor, pursuant
to which the Company will issue Common Stock to the Investor with an aggregate Purchase Price equal to the value of the Put, subject
to a price per share calculation based on the Market Price.

 

“Put
Amount” shall mean the total dollar amount requested by the Company pursuant to an applicable Put. The timing and amounts of
each Put shall be at the discretion of the Company. The maximum dollar amount of each Put will not exceed two hundred percent (200%)
of the average daily trading dollar volume for the Common Stock during the ten (10) consecutive Trading Days preceding the Put Notice
Date. No Put will be made in an amount equaling less than ten thousand dollars ($10,000) or greater than five hundred thousand dollars
($500,000). Puts are further limited to the Investor owning no more than 4.99% of the outstanding stock of the Company at any given time.

 

“Put
Notice” shall mean a written notice sent to the Investor by the Company stating the Put Amount in U.S. dollars that the Company
intends to sell to the Investor pursuant to the terms of the Agreement and stating the current number of Shares issued and outstanding
on such date.

 

“Put
Notice Date” shall mean the Trading Day on which the Investor receives a Put Notice.

 

“Put
Restriction” shall mean a minimum of ten (10) Trading Days following a Put Notice Date. During this time, the Company shall
not be entitled to deliver another Put Notice.

 

“Put
Shares” shall have the meaning set forth in Section 2.4.

 

“Registered
Offering Transaction Documents” shall mean this Agreement and the Registration Rights Agreement between the Company and the
Investor as of the date herewith.

 

“Registration
Rights Agreement” shall have the meaning set forth in the recitals.

 

“Registration
Statement” means the registration statement of the Company filed under the 1933 Act covering the Securities issuable hereunder.

 

“Related
Party” shall have the meaning set forth in Section 5.7.

 

“Resolution”
shall have the meaning set forth in Section 7.5.

 

    3

     

    

 

“SEC”
shall mean the U.S. Securities and Exchange Commission.

 

“SEC
Documents” shall have the meaning set forth in Section 4.6.

 

“Securities”
shall mean the shares of Common Stock issued pursuant to the terms of this Agreement.

 

“Settlement
Date” shall have the meaning set forth in Section 2.4.

 

“Shares”
shall mean the shares of the Common Stock.

 

“Subsidiaries”
shall have the meaning set forth in Section 4.1.

 

“Trading
Day” shall mean any day on which the Principal Market for the Common Stock is open for trading, from the hours of 9:30 am until
4:00 pm.

 

“Transaction
Costs” the Company shall bear the costs of the Registration Statement. At the Closing of the first Put, the Company shall deposit
six thousand dollars ($6,000) with the Investor’s designated legal counsel to offset legal costs.

 

SECTION
II

PURCHASE
AND SALE OF COMMON STOCK

 

2.1
PURCHASE AND SALE OF COMMON STOCK. Subject to the terms and conditions set forth herein, the Company shall issue and sell to the
Investor, and the Investor shall purchase from the Company, up to that number of Shares having an aggregate Purchase Price of Ten Million
Dollars ($10,000,000).

 

2.2
DELIVERY OF PUT NOTICES. Subject to the terms and conditions herein, and from time to time during the Open Period, the Company
may, in its sole discretion, deliver a Put Notice to the Investor which states the dollar amount (designated in U.S. Dollars), which
the Company intends to sell to the Investor on a Closing Date (the “Put”). The Put Notice shall be in the form attached
hereto as Exhibit C and incorporated herein by reference. The Purchase Price of the Put shall be eighty percent (80%) percent
of the Market Price. Following an up-list to the NASDAQ or equivalent national exchange, the Purchase Price shall be ninety percent (90%)
of the Market Price, subject to a floor price of $0.0001 per share, below which the Company shall not deliver a Put. During the Open
Period, the Company shall not be entitled to submit a Put Notice until after the previous Closing has been completed. There will be a
minimum of ten (10) trading days between Closings. No Put will be made in an amount equaling less than ten thousand dollars ($10,000)
or greater than five hundred thousand dollars ($500,000).

 

2.3
CONDITIONS TO INVESTOR’S OBLIGATION TO PURCHASE SHARES. Notwithstanding anything to the contrary in this Agreement, the
Company shall not be entitled to deliver a Put Notice and the Investor shall not be obligated to purchase any Shares at a Closing unless
each of the following conditions are satisfied:

 

		i.	a
                                            Registration Statement shall have been declared effective and shall remain effective and
                                            available for the resale of all the Registrable Securities (as defined in the Registration
                                            Rights Agreement) at all times until the Closing with respect to the subject Put Notice;

 

    4

     

    

 

		ii.	at
                                            all times during the period beginning on the related Put Notice Date and ending on and including
                                            the related Closing Date, the Common Stock shall have been listed or quoted for trading on
                                            the Principal Market and shall not have been suspended from trading thereon for a period
                                            of two (2) consecutive Trading Days during the Open Period and the Company shall not have
                                            been notified of any pending or threatened proceeding or other action to suspend the trading
                                            of the Common Stock;

 

		iii.	the
                                            Company has complied with its obligations and is otherwise not in breach of or in default
                                            under, this Agreement, the Registration Rights Agreement or any other agreement executed
                                            between the parties, which has not been cured prior to delivery of the Put Notice;

 

		iv.	no
                                            injunction shall have been issued and remain in force, or action commenced by a governmental
                                            authority which has not been stayed or abandoned, prohibiting the purchase or the issuance
                                            of the Securities; and

 

		v.	the
                                            issuance of the Securities will not violate any requirements of the Principal Market.

 

If
any of the events described in clauses (i) through (v) above occurs during a Pricing Period, then the Investor shall have no obligation
to purchase the Put Amount of Common Stock set forth in the applicable Put Notice. 

 

2.4
MECHANICS OF PURCHASE OF SHARES BY INVESTOR. Subject to the satisfaction of the conditions set forth in Sections 2.5, 7 and
8 of this Agreement, at the end of the Pricing Period, the Purchase Price shall be established and an amount of Shares equaling one hundred
percent (100%) of the Put Amount (the “Put Shares”) shall be delivered to the Investor’s broker for a particular
Put.

The Closing of a Put shall occur upon the first Trading Day following the confirmation of receipt and approval for trading by Investor’s
broker of the Put Shares, whereby the Company shall have caused the Transfer Agent to electronically transmit, prior to the applicable
Closing Date, the applicable Put Shares by crediting the account of the Investor’s broker with DTC through its Deposit Withdrawal
Agent Commission (“DWAC”) system. The Investor shall deliver the Purchase Amount specified in the Put Notice (less
deposit and clearing fees) by wire transfer of immediately available funds to an account designated by the Company if the aforementioned
receipt and approval are confirmed before 9:30 AM ET or on the following Trading Day if receipt and approval by the Investor’s
broker is made after 9:30 AM ET (“Closing Date” or “Closing”). In addition, on or prior to such
Closing Date, each of the Company and Investor shall deliver to each other all documents, instruments and writings required to be delivered
or reasonably requested by either of them pursuant to this Agreement in order to implement and effect the transactions contemplated herein.

 

2.5
OVERALL LIMIT ON COMMON STOCK ISSUABLE. Notwithstanding anything contained herein to the contrary, if during the Open Period the
Company becomes listed on an exchange which limits the number of shares of Common Stock that may be issued without shareholder approval,
then the number of Shares issuable by the Company and purchasable by the Investor, shall not exceed that number of the shares of Common
Stock that may be issuable without shareholder approval (the “Maximum Common Stock Issuance”). If such issuance of
shares of Common Stock could cause a delisting on the Principal Market then the Maximum Common Stock Issuance shall first be approved
by the Company’s shareholders in accordance with applicable law and the By-laws and the Articles of Incorporation of the Company.
The parties understand and agree that the Company’s failure to seek or obtain such shareholder approval shall in no way adversely
affect the validity and due authorization of the issuance and sale of Securities or the Investor’s obligation in accordance with
the terms and conditions hereof to purchase a number of Shares in the aggregate up to the Maximum Common Stock Issuance, and that such
approval pertains only to the applicability of the Maximum Common Stock Issuance limitation provided in this Section 2.5.

 

    5

     

    

 

2.6
LIMITATION ON AMOUNT OF OWNERSHIP. Notwithstanding anything to the contrary in this Agreement, in no event shall the Investor
be entitled to purchase that number of Shares, which when added to the sum of the number of shares of Common Stock beneficially owned
(as such term is defined under Section 13(d) and Rule 13d-3 of the 1934 Act), by the Investor, would exceed 4.99% of the number
of shares of Common Stock outstanding on the Closing Date, as determined in accordance with Rule 13d-1(j) of the 1934 Act.

 

2.7
Equity Incentive. Concurrent with the execution of definitive agreements, the Company shall issue 29,069,768 shares to the Investor
(“Equity Incentive”). (One Percent of the commitment amount, calculated at the Purchase Price applicable at execution). The
Equity Incentive will be deemed earned upon the execution of definitive agreements.

 

SECTION
III

INVESTOR’S REPRESENTATIONS, WARRANTIES AND COVENANTS

 

The
Investor represents and warrants to the Company, and covenants, that to the best of the Investor’s knowledge:

 

3.1
SOPHISTICATED INVESTOR. The Investor has, by reason of its business and financial experience, such knowledge, sophistication and
experience in financial and business matters and in making investment decisions of this type that it is capable of (I) evaluating the
merits and risks of an investment in the Securities and making an informed investment decision; (II) protecting its own interest; and
(III) bearing the economic risk of such investment for an indefinite period of time.

 

3.2
AUTHORIZATION; ENFORCEMENT. This Agreement has been duly and validly authorized, executed and delivered on behalf of the Investor
and is a valid and binding agreement of the Investor enforceable against the Investor in accordance with its terms, subject as to enforceability
to general principles of equity and to applicable bankruptcy, insolvency, reorganization, moratorium, liquidation and other similar laws
relating to, or affecting generally, the enforcement of applicable creditors’ rights and remedies.

 

3.3
SECTION 9 OF THE 1934 ACT. During the term of this Agreement, the Investor will comply with the provisions of Section 9
of the 1934 Act, and the rules promulgated thereunder, with respect to transactions involving the Common Stock.

 

3.4
ACCREDITED INVESTOR. Investor is an “Accredited Investor” as that term is defined in Rule 501(a) of Regulation
D of the 1933 Act.

 

3.5
NO CONFLICTS. The execution, delivery and performance of the Documents by the Investor and the consummation by the Investor of
the transactions contemplated hereby and thereby will not result in a violation of Partnership Agreement or other organizational documents
of the Investor.

 

3.6
OPPORTUNITY TO DISCUSS. The Investor has received all materials relating to the Company’s business, finance and operations
which it has requested. The Investor has had an opportunity to discuss the business, management and financial affairs of the Company
with the Company’s management.

 

    6

     

    

 

3.7
INVESTMENT PURPOSES. The Investor is purchasing the Securities for its own account for investment purposes and not with a view
towards distribution and agrees to resell or otherwise dispose of the Securities solely in accordance with the registration provisions
of the 1933 Act (or pursuant to an exemption from such registration provisions).

 

3.8
GOOD STANDING. The Investor is a limited liability company, duly organized, validly existing and in good standing in the State
of Nevada.

 

3.9
TAX LIABILITIES. The Investor understands that it is liable for its own tax liabilities.

 

3.10
REGULATION M. The Investor will comply with Regulation M under the 1934 Act, if applicable.

 

3.11
PROHIBITED TRADING. No short sales shall be permitted by the Investor or its affiliates
during the period commencing on the Execution Date and continuing through the termination of this Agreement.

 

SECTION
IV

REPRESENTATIONS
AND WARRANTIES OF THE COMPANY

 

Except
as set forth in the Schedules attached hereto, or as disclosed on the Company’s SEC Documents, the Company represents and warrants
to the Investor that:

 

4.1
ORGANIZATION AND QUALIFICATION. The Company is a corporation duly organized and validly existing in good standing under the laws
of the State of Nevada, and has the requisite corporate power and authorization to own its properties and to carry on its business as
now being conducted. Both the Company and the companies it owns or controls (“Subsidiaries”) are duly qualified to
do business and are in good standing in every jurisdiction in which its ownership of property or the nature of the business conducted
by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good standing would not have
a Material Adverse Effect. As used in this Agreement, “Material Adverse Effect” means a change, event, circumstance,
effect or state of facts that has had or is reasonably likely to have, a material adverse effect on the business, properties, assets,
operations, results of operations, financial condition or prospects of the Company and its Subsidiaries, if any, taken as a whole, or
on the transactions contemplated hereby or by the agreements and instruments to be entered into in connection herewith, or on the authority
or ability of the Company to perform its obligations under the Registered offering Transaction Documents.

 

4.2
AUTHORIZATION; ENFORCEMENT; COMPLIANCE WITH OTHER INSTRUMENTS.

 

		i.	The
                                            Company has the requisite corporate power and authority to enter into and perform this Agreement
                                            and the Registration Rights Agreement (collectively, the “Registered Offering Transaction
                                            Documents”), and to issue the Securities in accordance with the terms hereof and
                                            thereof.

 

		ii.	The
                                            execution and delivery of the Registered Offering Transaction Documents by the Company and
                                            the consummation by it of the transactions contemplated hereby and thereby, including without
                                            limitation the issuance of the Securities pursuant to this Agreement, have been duly and
                                            validly authorized by the Company’s Board of Directors and no further consent or authorization
                                            is required by the Company, its Board of Directors, or its shareholders.

 

    7

     

    

 

		iii.	The
                                            Registered Offering Transaction Documents have been duly and validly executed and delivered
                                            by the Company.

 

		iv.	The
                                            Registered Offering Transaction Documents constitute the valid and binding obligations of
                                            the Company enforceable against the Company in accordance with their terms, except as such
                                            enforceability may be limited by general principles of equity or applicable bankruptcy, insolvency,
                                            reorganization, moratorium, liquidation or similar laws relating to, or affecting generally,
                                            the enforcement of creditors’ rights and remedies.

 

4.3
CAPITALIZATION. As of the date hereof, the authorized capital stock of the Company consists of: (i) 2,000,000,000 shares of Common
Stock, par value $0.0001 per share, and (ii) 20,000,000 shares of Preferred Stock, par value $0.0001 per share, of which 5,000,000 shares
are designated as Series A Convertible Preferred Stock and 2,500 are designated as Series B Preferred Stock. As of the date hereof, (i)
1,474,473,903 shares of Common Stock are issued and outstanding, all of which are duly authorized, validly issued, fully paid and non-assessable,
(ii) 4,250,579 shares of Series A Stock are issued and outstanding, all of which are duly authorized, validly issued, fully paid and
non-assessable, (iii) 1,795 shares of Series B Preferred Stock are issued and outstanding all of which are duly authorized, validly issued,
fully paid and non-assessable; and (iv) 525,526,097 shares of Common Stock are reserved for future issuances.

Except as disclosed in the Company’s publicly available filings with the SEC and as will be disclosed in the Registration Statement,
and based on the best information available and efforts of the Company’s management, or as otherwise set forth on Schedule 4.3:

 

		i.	no
                                            shares of the Company’s capital stock are subject to preemptive rights or any other
                                            similar rights or any liens or encumbrances suffered or permitted by the Company;

 

		ii.	there
                                            are no outstanding debt securities;

 

		iii.	there
                                            are no outstanding shares of capital stock, options, warrants, scrip, rights to subscribe
                                            to, calls or commitments of any character whatsoever relating to, or securities or rights
                                            convertible into, any shares of capital stock of the Company or any of its Subsidiaries,
                                            or contracts, commitments, understandings or arrangements by which the Company or any of
                                            its Subsidiaries is or may become bound to issue additional shares of capital stock of the
                                            Company or any of its Subsidiaries or options, warrants, scrip, rights to subscribe to, calls
                                            or commitments of any character whatsoever relating to, or securities or rights convertible
                                            into, any shares of capital stock of the Company or any of its Subsidiaries;

 

		iv.	there
                                            are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated
                                            to register the sale of any of their securities under the 1933 Act (except the Registration
                                            Rights Agreement);

 

		v.	there
                                            are no outstanding securities of the Company or any of its Subsidiaries which contain any
                                            redemption or similar provisions, and there are no contracts, commitments, understandings
                                            or arrangements by which the Company or any of its Subsidiaries is or may become bound to
                                            redeem a security of the Company or any of its Subsidiaries;

 

		vi.	there
                                            are no securities or instruments containing anti-dilution or similar provisions that will
                                            be triggered by the issuance of the Securities as described in this Agreement;

 

    8

     

    

 

		vii.	the
                                            Company does not have any stock appreciation rights or “phantom stock” plans
                                            or agreements or any similar plan or agreement; and

 

		viii.	there
                                            is no dispute as to the classification of any shares of the Company’s capital stock.

 

The
Company has furnished to the Investor, or the Investor has had access through EDGAR to, true and correct copies of the Company’s
Articles of Incorporation and all amendments thereto, as in effect on the date hereof (the “Articles of Incorporation”),
and the Company’s By-laws and all amendments thereto, as in effect on the date hereof (the “By-laws”), and the
terms of all securities convertible into or exercisable for Common Stock and the material rights of the holders thereof in respect thereto.

 

4.4
ISSUANCE OF SHARES. As of the filing of the Registration Statement the Company will have reserved the amount of Shares included
in the Registration Statement for issuance pursuant to the Registered Offering Transaction Documents, which have been duly authorized
and reserved (subject to adjustment pursuant to the Company’s covenant set forth in Section 5.5 below) pursuant to
this Agreement. Upon issuance in accordance with this Agreement, the Securities will be validly issued, fully paid for and non-assessable
and free from all taxes, liens and charges with respect to the issuance thereof. In the event the Company cannot register a sufficient
number of Shares for issuance pursuant to this Agreement, the Company will use its best efforts to authorize and reserve for issuance
the number of Shares required for the Company to perform its obligations hereunder as soon as reasonably practicable.

 

4.5
NO CONFLICTS. The execution, delivery and performance of the Registered Offering Transaction Documents by the Company and the
consummation by the Company of the transactions contemplated hereby and thereby will not (i) result in a violation of the Articles of
Incorporation, any Certificate of Designations, Preferences and Rights of any outstanding series of preferred stock of the Company or
the By-laws; or (ii) conflict with, or constitute a material default (or an event which with notice or lapse of time or both would become
a material default) under, or give to others any rights of termination, amendment, acceleration or cancellation of, any material agreement,
contract, indenture mortgage, indebtedness or instrument to which the Company or any of its Subsidiaries is a party, or to the Company’s
knowledge result in a violation of any law, rule, regulation, order, judgment or decree (including United States federal and state securities
laws and regulations and the rules and regulations of the Principal Market or principal securities exchange or trading market on which
the Common Stock is traded or listed) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company
or any of its Subsidiaries is bound or affected. Neither the Company nor its Subsidiaries is in violation of any term of, or in default
under, the Articles of Incorporation, any Certificate of Designations, Preferences and Rights of any outstanding series of preferred
stock of the Company or the By-laws or their organizational charter or by-laws, respectively, or any contract, agreement, mortgage, indebtedness,
indenture, instrument, judgment, decree or order or any statute, rule or regulation applicable to the Company or its Subsidiaries, except
for possible conflicts, defaults, terminations, amendments, accelerations, cancellations and violations that would not individually or
in the aggregate have or constitute a Material Adverse Effect. The business of the Company and its Subsidiaries is not being conducted,
and shall not be conducted, in violation of any law, statute, ordinance, rule, order or regulation of any governmental authority or agency,
regulatory or self-regulatory agency, or court, except for possible violations the sanctions for which either individually or in the
aggregate would not have a Material Adverse Effect. Except as specifically contemplated by this Agreement and as required under the 1933
Act or any securities laws of any states, to the Company’s knowledge, the Company is not required to obtain any consent, authorization,
permit or order of, or make any filing or registration (except the filing of a registration statement as outlined in the Registration
Rights Agreement between the parties) with, any court, governmental authority or agency, regulatory or self-regulatory agency or other
third party in order for it to execute, deliver or perform any of its obligations under, or contemplated by, the Registered Offering
Transaction Documents in accordance with the terms hereof or thereof. All consents, authorizations, permits, orders, filings and registrations
which the Company is required to obtain pursuant to the preceding sentence have been obtained or effected on or prior to the date hereof
and are in full force and effect as of the date hereof. The Company and its Subsidiaries are unaware of any facts or circumstances which
might give rise to any of the foregoing. The Company is not, and will not be, in violation of the listing requirements of the Principal
Market as in effect on the date hereof and on each of the Closing Dates and is not aware of any facts which would reasonably lead to
delisting of the Common Stock by the Principal Market in the foreseeable future.

 

    9

     

    

 

4.6
SEC DOCUMENTS; FINANCIAL STATEMENTS. As of the date hereof, the Company has filed all reports, schedules, forms, statements and
other documents required to be filed by it with the SEC pursuant to the reporting requirements of the 1934 Act (all of the foregoing
filed prior to the date hereof and all exhibits included therein and financial statements and schedules thereto and documents incorporated
by reference therein, and amendments thereto, being hereinafter referred to as the “SEC Documents”). The Company has
delivered to the Investor or its representatives, or they have had access through EDGAR to, true and complete copies of the SEC Documents.
As of their respective filing dates, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the
rules and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they
were filed with the SEC or the time they were amended, if amended, contained any untrue statement of a material fact or omitted to state
a material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which
they were made, not misleading. As of their respective dates, the financial statements of the Company included in the SEC Documents complied
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC with respect
thereto. Such financial statements have been prepared in accordance with generally accepted accounting principles, by a firm that is
a member of the Public Companies Accounting Oversight Board (“PCAOB”) consistently applied, during the periods involved
(except (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited interim
statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material respects
the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods then ended
(subject, in the case of unaudited statements, to normal year-end audit adjustments). No other written information provided by or on
behalf of the Company to the Investor which is not included in the SEC Documents, including, without limitation, information referred
to in Section 4.3 of this Agreement, contains any untrue statement of a material fact or omits to state any material fact
necessary to make the statements therein, in the light of the circumstance under which they are or were made, not misleading. Neither
the Company nor any of its Subsidiaries or any of their officers, directors, employees or agents have provided the Investor with any
material, nonpublic information which was not publicly disclosed prior to the date hereof and any material, nonpublic information provided
to the Investor by the Company or its Subsidiaries or any of their officers, directors, employees or agents prior to any Closing Date
shall be publicly disclosed by the Company prior to such Closing Date.

 

4.7
ABSENCE OF CERTAIN CHANGES. Except as otherwise set forth in the SEC Documents, the Company does not intend to change the business
operations of the Company in any material way. The Company has not taken any steps, and does not currently expect to take any steps,
to seek protection pursuant to any bankruptcy law nor does the Company or its Subsidiaries have any knowledge or reason to believe that
its creditors intend to initiate involuntary bankruptcy proceedings.

 

4.8
ABSENCE OF LITIGATION AND/OR REGULATORY PROCEEDINGS. Except as set forth in the SEC Documents, there is no action, suit, proceeding,
inquiry or investigation before or by any court, public board, government agency, self-regulatory organization or body pending or, to
the knowledge of the executive officers of Company or any of its Subsidiaries, threatened against or affecting the Company, the Common
Stock or any of the Company’s Subsidiaries or any of the Company’s or the Company’s Subsidiaries’ officers or
directors in their capacities as such, in which an adverse decision could have a Material Adverse Effect.

 

    10

     

    

 

4.9
ACKNOWLEDGMENT REGARDING INVESTOR’S PURCHASE OF SHARES. The Company acknowledges and agrees that the Investor is
acting solely in the capacity of an arm’s length investor with respect to the Registered Offering Transaction Documents
and the transactions contemplated hereby and thereby. The Company further acknowledges that the Investor is not acting as a financial
advisor or fiduciary of the Company (or in any similar capacity) with respect to the Registered Offering Transaction Documents
and the transactions contemplated hereby and thereby and any advice given by the Investor or any of its respective representatives
or agents in connection with the Registered Offering Transaction Documents and the transactions contemplated hereby and thereby
is merely incidental to the Investor’s purchase of the Securities, and is not being relied on by the Company. The Company
further represents to the Investor that the Company’s decision to enter into the Registered Offering Transaction Documents
has been based solely on the independent evaluation by the Company and its representatives.

 

4.10
NO UNDISCLOSED EVENTS, LIABILITIES, DEVELOPMENTS OR CIRCUMSTANCES. Except as set forth in the SEC Documents, as of the date hereof,
no event, liability, development or circumstance has occurred or exists, or to the Company’s knowledge is contemplated to occur,
with respect to the Company or its Subsidiaries or their respective business, properties, assets, prospects, operations or financial
condition, that would be required to be disclosed by the Company under applicable securities laws on a registration statement filed with
the SEC relating to an issuance and sale by the Company of its Common Stock and which has not been publicly announced.

 

4.11
EMPLOYEE RELATIONS. Neither the Company nor any of its Subsidiaries is involved in any union labor dispute nor, to the knowledge
of the Company or any of its Subsidiaries, is any such dispute threatened. Neither the Company nor any of its Subsidiaries is a party
to a collective bargaining agreement, and the Company and its Subsidiaries believe that relations with their employees are good. No executive
officer (as defined in Rule 501(f) of the 1933 Act) has notified the Company that such officer intends to leave the Company’s
employ or otherwise terminate such officer’s employment with the Company.

 

4.12
INTELLECTUAL PROPERTY RIGHTS. The Company and its Subsidiaries own or possess adequate rights or licenses to use all trademarks,
trade names, service marks, service mark registrations, service names, patents, patent rights, copyrights, inventions, licenses, approvals,
governmental authorizations, trade secrets and rights necessary to conduct their respective businesses as now conducted. Except as set
forth in the SEC Documents, none of the Company’s trademarks, trade names, service marks, service mark registrations, service names,
patents, patent rights, copyrights, inventions, licenses, approvals, government authorizations, trade secrets or other intellectual property
rights necessary to conduct its business as now or as proposed to be conducted have expired or terminated, or are expected to expire
or terminate within three (3) years from the date of this Agreement. The Company and its Subsidiaries do not have any knowledge of any
infringement by the Company or its Subsidiaries of trademark, trade name rights, patents, patent rights, copyrights, inventions, licenses,
service names, service marks, service mark registrations, trade secret or other similar rights of others, or of any such development
of similar or identical trade secrets or technical information by others and, except as set forth in the SEC Documents, there is no claim,
action or proceeding being made or brought against, or to the Company’s knowledge, being threatened against, the Company or its
Subsidiaries regarding trademark, trade name, patents, patent rights, invention, copyright, license, service names, service marks, service
mark registrations, trade secret or other infringement; and the Company and its Subsidiaries are unaware of any facts or circumstances
which might give rise to any of the foregoing. The Company and its Subsidiaries have taken commercially reasonable security measures
to protect the secrecy, confidentiality and value of all of their intellectual properties.

 

    11

     

    

 

4.13
ENVIRONMENTAL LAWS. The Company and its Subsidiaries (i) are, to the knowledge of the management and directors of the Company
and its Subsidiaries, in compliance with any and all applicable foreign, federal, state and local laws and regulations relating to the
protection of human health and safety, the environment or hazardous or toxic substances or wastes, pollutants or contaminants (“Environmental
Laws”); (ii) have, to the knowledge of the management and directors of the Company, received all permits, licenses or other
approvals required of them under applicable Environmental Laws to conduct their respective businesses; and (iii) are in compliance, to
the knowledge of the management and directors of the Company, with all terms and conditions of any such permit, license or approval where,
in each of the three (3) foregoing cases, the failure to so comply would have, individually or in the aggregate, a Material Adverse Effect.

 

4.14
TITLE. The Company and its Subsidiaries have good and marketable title to all personal property owned by them which is material
to the business of the Company and its Subsidiaries, in each case free and clear of all liens, encumbrances and defects except such as
are described in the SEC Documents or such as do not materially affect the value of such property and do not interfere with the use made
and proposed to be made of such property by the Company or any of its Subsidiaries. Any real property and facilities held under lease
by the Company or any of its Subsidiaries are held by them under valid, subsisting and enforceable leases with such exceptions as are
not material and do not interfere with the use made and proposed to be made of such property and buildings by the Company and its Subsidiaries.

 

4.15
[INTENTIONALLY OMIITTED]

 

4.16
REGULATORY PERMITS. The Company and its Subsidiaries have in full force and effect all certificates, approvals, authorizations
and permits from the appropriate federal, state, local or foreign regulatory authorities and comparable foreign regulatory agencies,
necessary to own, lease or operate their respective properties and assets and conduct their respective businesses, and neither the Company
nor any such Subsidiary has received any notice of proceedings relating to the revocation or modification of any such certificate, approval,
authorization or permit, except for such certificates, approvals, authorizations or permits which if not obtained, or such revocations
or modifications which, would not have a Material Adverse Effect.

 

4.17
INTERNAL ACCOUNTING CONTROLS. Except as otherwise set forth in the SEC Documents, the Company and each of its Subsidiaries maintain
a system of internal accounting controls sufficient to provide reasonable assurance that (i) transactions are executed in accordance
with management’s general or specific authorizations; (ii) transactions are recorded as necessary to permit preparation of financial
statements in conformity with generally accepted accounting principles by a firm with membership to the PCAOB and to maintain asset accountability;
(iii) access to assets is permitted only in accordance with management’s general or specific authorization; and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to
any differences. The Company’s management has determined that the Company’s internal accounting controls were not effective
as of the date of this Agreement as further described in the SEC Documents.

 

4.18
NO MATERIALLY ADVERSE CONTRACTS, ETC. Neither the Company nor any of its Subsidiaries is subject to any charter, corporate or
other legal restriction, or any judgment, decree, order, rule or regulation which in the judgment of the Company’s officers has
or is expected in the future to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party to any contract
or agreement which in the judgment of the Company’s officers has or is expected to have a Material Adverse Effect.

 

    12

     

    

 

4.19
[INTENTIONALLY OMITTED]

 

4.20
CERTAIN TRANSACTIONS. Except as set forth in the SEC Documents filed at least ten (10) days prior to the date hereof and except
for arm’s length transactions pursuant to which the Company makes payments in the ordinary course of business upon terms no less
favorable than the Company could obtain from disinterested third parties, none of the officers, directors, or employees of the Company
is presently a party to any transaction with the Company or any of its Subsidiaries (other than for services as employees, officers and
directors), including any contract, agreement or other arrangement providing for the furnishing of services to or by, providing for rental
of real or personal property to or from, or otherwise requiring payments to or from any officer, director or such employee or, to the
knowledge of the Company, any corporation, partnership, trust or other entity in which any officer, director, or any such employee has
a substantial interest or is an officer, director, trustee or partner, such that disclosure would be required in the SEC Documents..

 

4.21
DILUTIVE EFFECT. The Company understands and acknowledges that the number of shares of Common Stock issuable upon purchases pursuant
to this Agreement will increase in certain circumstances including, but not necessarily limited to, the circumstance wherein the trading
price of the Common Stock declines during the period between the Effective Date and the end of the Open Period. The Company’s executive
officers and directors have studied and fully understand the nature of the transactions contemplated by this Agreement and recognize
that they have a potential dilutive effect on the shareholders of the Company. The Board of Directors of the Company has concluded, in
its good faith business judgment, and with full understanding of the implications, that such issuance is in the best interests of the
Company. The Company specifically acknowledges that, subject to such limitations as are expressly set forth in the Registered Offering
Transaction Documents, its obligation to issue shares of Common Stock upon purchases pursuant to this Agreement is absolute and unconditional
regardless of the dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

4.22
NO GENERAL SOLICITATION. Neither the Company, nor any of its affiliates, nor any person acting on its behalf, has engaged in any
form of general solicitation or general advertising (within the meaning of Regulation D) in connection with the offer or sale of the
Common Stock to be offered as set forth in this Agreement.

 

4.23
NO BROKERS, FINDERS OR FINANCIAL ADVISORY FEES OR COMMISSIONS. Other than Network 1, no brokers, finders or financial advisory
fees or commissions will be payable by the Company, its agents or Subsidiaries, with respect to the transactions contemplated by this
Agreement.

 

4.24
EXCLUSIVITY. The Company shall not pursue a similar equity financing transaction as envisioned hereunder (the “Equity Financing”)
with any other party unless and until good faith negotiations have terminated between the Investor and the Company or until such time
as the Registration Statement has been declared effective by the SEC.

 

    13

     

    

 

SECTION
V

COVENANTS
OF THE COMPANY

 

5.1
BEST EFFORTS. The Company shall use all commercially reasonable efforts to timely satisfy each of the conditions set forth in
Section 7 of this Agreement.

 

5.2
REPORTING STATUS. Until one of the following occurs, the Company shall file all reports required to be filed with the SEC pursuant
to the 1934 Act, and the Company shall not terminate its status, or take an action or fail to take any action, which would terminate
its status as a reporting company under the 1934 Act: (i) this Agreement terminates pursuant to Section 8 and the Investor
has the right to sell all of the Securities without restrictions pursuant to Rule 144 promulgated under the 1933 Act, or such other
exemption, or (ii) the date on which the Investor has sold all the Securities and this Agreement has been terminated pursuant to Section 8.

 

5.3
USE OF PROCEEDS. The Company will use the proceeds from the sale of the Put Shares (excluding amounts paid by the Company for
fees as set forth in the Registered Offering Transaction Documents) for general corporate and working capital purposes and acquisitions
or assets, businesses or operations or for other purposes that the Board of Directors, in good faith, deem to be in the best interest
of the Company.

 

5.4
FINANCIAL INFORMATION. During the Open Period, the Company agrees to make available to the Investor via EDGAR or other electronic
means the following documents and information on the forms set forth: (i) within five (5) Trading Days after the filing thereof with
the SEC, a copy of its Annual Reports on Form 10-K, its Quarterly Reports on Form 10-Q, any Current Reports on Form 8-K
and any Registration Statements or amendments filed pursuant to the 1933 Act; (ii) copies of any notices and other information made available
or given to the shareholders of the Company generally, contemporaneously with the making available or giving thereof to the shareholders;
and (iii) within two (2) calendar days of filing or delivery thereof, copies of all documents filed with, and all correspondence sent
to, the Principal Market, any securities exchange or market, or the Financial Industry Regulatory Association, unless such information
is material nonpublic information.

 

5.5
RESERVATION OF SHARES. The Company shall take all action necessary to at all times have authorized, and reserved the amount of
Shares included in the Company’s registration statement for issuance pursuant to the Registered Offering Transaction Documents.
In the event that the Company determines that it does not have a sufficient number of authorized shares of Common Stock to reserve and
keep available for issuance as described in this Section 5.5, the Company shall use all commercially reasonable efforts to
increase the number of authorized shares of Common Stock by seeking shareholder approval for the authorization of such additional shares.

 

5.6
LISTING. The Company shall promptly secure and maintain the listing of all of the Registrable Securities (as defined in the Registration
Rights Agreement) on the Principal Market and each other national securities exchange and automated quotation system, if any, upon which
shares of Common Stock are then listed (subject to official notice of issuance) and shall maintain, such listing of all Registrable Securities
from time to time issuable under the terms of the Registered Offering Transaction Documents. Neither the Company nor any of its Subsidiaries
shall take any action which would be reasonably expected to result in the delisting or suspension of the Common Stock on the Principal
Market (excluding suspensions of not more than one (1) Trading Day resulting from business announcements by the Company). The Company
shall promptly provide to the Investor copies of any notices it receives from the Principal Market regarding the continued eligibility
of the Common Stock for listing on such automated quotation system or securities exchange. The Company shall pay all fees and expenses
in connection with satisfying its obligations under this Section 5.6.

 

    14

     

    

 

5.7
TRANSACTIONS WITH AFFILIATES. The Company shall not, and shall cause each of its Subsidiaries not to, enter into, amend, modify
or supplement, or permit any Subsidiary to enter into, amend, modify or supplement, any agreement, transaction, commitment or arrangement
with any of its or any Subsidiary’s officers, directors, persons who were officers or directors at any time during the previous
two (2) years, shareholders who beneficially own 5% or more of the Common Stock, or Affiliates or with any individual related by blood,
marriage or adoption to any such individual or with any entity in which any such entity or individual owns a 5% or more beneficial interest
(each a “Related Party”), except for (i) customary employment arrangements and benefit programs on reasonable terms,
(ii) any agreement, transaction, commitment or arrangement on an arms-length basis on terms no less favorable than terms which would
have been obtainable from a disinterested third party other than such Related Party, or (iii) any agreement, transaction, commitment
or arrangement which is approved by a majority of the disinterested directors of the Company. For purposes hereof, any director who is
also an officer of the Company or any Subsidiary of the Company shall not be a disinterested director with respect to any such agreement,
transaction, commitment or arrangement. “Affiliate” for purposes hereof means, with respect to any person or entity,
another person or entity that, directly or indirectly, (i) has a 5% or more equity interest in that person or entity, (ii) has 5% or
more common ownership with that person or entity, (iii) controls that person or entity, or (iv) is under common control with that person
or entity. “Control” or “Controls” for purposes hereof means that a person or entity has the power,
directly or indirectly, to conduct or govern the policies of another person or entity.

 

5.8
FILING OF FORM 8-K. On or before the date which is four (4) Trading Days after the Execution Date, the Company shall file
a Current Report on Form 8-K with the SEC describing the terms of the transaction contemplated by the Registered Offering Transaction
Documents in the form required by the 1934 Act, if such filing is required.

 

5.9
CORPORATE EXISTENCE. The Company shall use all commercially reasonable efforts to preserve and continue the corporate existence
of the Company.

 

5.10
NOTICE OF CERTAIN EVENTS AFFECTING REGISTRATION; SUSPENSION OF RIGHT TO MAKE A PUT. The Company shall promptly notify the Investor
upon the occurrence of any of the following events in respect of a Registration Statement or related prospectus in respect of an offering
of the Securities: (i) receipt of any request for additional information by the SEC or any other federal or state governmental authority
during the period of effectiveness of the Registration Statement for amendments or supplements to the Registration Statement or related
prospectus; (ii) the issuance by the SEC or any other federal or state governmental authority of any stop order suspending the effectiveness
of any Registration Statement or the initiation of any proceedings for that purpose; (iii) receipt of any notification with respect to
the suspension of the qualification or exemption from qualification of any of the Securities for sale in any jurisdiction or the initiation
or notice of any proceeding for such purpose; (iv) the happening of any event that makes any statement made in such Registration Statement
or related prospectus or any document incorporated or deemed to be incorporated therein by reference untrue in any material respect or
that requires the making of any changes in the Registration Statement, related prospectus or documents so that, in the case of a Registration
Statement, it will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein
or necessary to make the statements therein not misleading, and that in the case of the related prospectus, it will not contain any untrue
statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading; and (v) the Company’s reasonable determination that
a post-effective amendment or supplement to the Registration Statement would be appropriate, and the Company shall promptly make available
to Investor any such supplement or amendment to the related prospectus. The Company shall not deliver to Investor any Put Notice during
the continuation of any of the foregoing events in this Section 5.10.

 

    15

     

    

 

5.11
TRANSFER AGENT. The Company shall deliver instructions to its transfer agent to issue Shares to the Investor that are issued to
the Investor pursuant to the Equity Financing and transactions contemplated herein.

 

5.12
ACKNOWLEDGEMENT OF TERMS. The Company hereby represents and warrants to the Investor that: (i) it is voluntarily entering into
this Agreement of its own free will, (ii) it is not entering this Agreement under economic duress, (iii) the terms of this Agreement
are reasonable and fair to the Company, and (iv) the Company has had independent legal counsel of its own choosing review this Agreement,
advise the Company with respect to this Agreement, and represent the Company in connection with this Agreement.

 

SECTION
VI

CONDITIONS
OF THE COMPANY’S OBLIGATION TO SELL

 

The
obligation hereunder of the Company to issue and sell the Securities to the Investor is further subject to the satisfaction, at or before
each Closing Date, of each of the following conditions set forth below. These conditions are for the Company’s sole benefit and
may be waived by the Company at any time in its sole discretion.

 

6.1
The Investor shall have executed this Agreement and the Registration Rights Agreement and delivered the same to the Company.

 

6.2
The Investor shall have delivered to the Company the Purchase Price for the Securities being purchased by the Investor.

 

6.3
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.

 

SECTION
VII

FURTHER
CONDITIONS OF THE INVESTOR’S OBLIGATION TO PURCHASE

 

The
obligation of the Investor hereunder to purchase Securities is subject to the satisfaction, on or before each Closing Date, of each of
the following conditions set forth below.

 

7.1
The Company shall have executed the Registered Offering Transaction Documents and delivered the same to the Investor.

 

7.2
The representations and warranties of the Company shall be true and correct as of the date when made and as of the applicable Closing
Date as though made at that time and the Company shall have performed, satisfied and complied with the covenants, agreements and conditions
required by the Registered Offering Transaction Documents to be performed, satisfied or complied with by the Company on or before such
Closing Date. The Investor may request an update as of such Closing Date regarding the representation contained in Section 4.3.

 

7.3
The Company shall have executed and delivered to the Investor via DWAC the Securities (in such denominations as the Investor shall request)
being purchased by the Investor at such Closing.

 

7.4
The Board of Directors of the Company shall have adopted resolutions consistent with Section 4.2(ii) (the “Resolutions”)
and such Resolutions shall not have been amended or rescinded prior to such Closing Date.

 

    16

     

    

 

7.5
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or governmental authority of competent jurisdiction which prohibits the consummation of any of the transactions contemplated
by this Agreement.

 

7.6
Within thirty (30) calendar days after the Agreement is executed, the Company agrees to use its best efforts to file with the SEC the
Registration Statement covering the shares of stock underlying the Equity Financing contemplated herein. Such Registration Statement
shall conform to the requirements of the rules and regulations of the SEC, and be subject to the reasonable approval of the Investor.
The Company will take any and all steps necessary to have its Registration Statement declared effective by the SEC within 30 calendar
days but no more than 90 calendar days after the Company has filed its Registration Statement. The Registration Statement shall be effective
on each Closing Date and no stop order suspending the effectiveness of the Registration statement shall be in effect or to the Company’s
knowledge shall be pending or threatened. Furthermore, on each Closing Date (I) neither the Company nor the Investor shall have received
notice that the SEC has issued or intends to issue a stop order with respect to such Registration Statement or that the SEC otherwise
has suspended or withdrawn the effectiveness of such Registration Statement, either temporarily or permanently, or intends or has threatened
to do so (unless the SEC’s concerns have been addressed), and (II) no other suspension of the use or withdrawal of the effectiveness
of such Registration Statement or related prospectus shall exist.

 

7.7
At the time of each Closing, the Registration Statement (including information or documents incorporated by reference therein) and any
amendments or supplements thereto shall not contain any untrue statement of a material fact or omit to state any material fact required
to be stated therein or necessary to make the statements therein not misleading or which would require public disclosure or an update
supplement to the prospectus.

 

7.8
If applicable, the shareholders of the Company shall have approved the issuance of any Shares in excess of the Maximum Common Stock Issuance
in accordance with Section 2.5 or the Company shall have obtained appropriate approval pursuant to the requirements of applicable
state and federal laws and the Company’s Articles of Incorporation and By-laws.

 

7.9
The conditions to such Closing set forth in Section 2.3 shall have been satisfied on or before such Closing Date.

 

7.10
The Company shall have certified to the Investor the number of Shares of Common Stock outstanding when a Put Notice is given to the Investor.
The Company’s delivery of a Put Notice to the Investor constitutes the Company’s certification of the existence of the necessary
number of shares of Common Stock reserved for issuance.

 

SECTION
VIII

TERMINATION

 

This
Agreement shall terminate upon any of the following events:

 

8.1
when the Investor has purchased an aggregate of Ten Million Dollars ($10,000,000) in the Common Stock of the Company pursuant to this
Agreement; or

 

8.2
twenty four (24) months from the date of this Agreement’s execution have elapsed.

 

Any
and all shares, or penalties, if any, due under this Agreement shall be immediately payable and due upon termination of this Agreement.

 

    17

     

    

 

SECTION
IX

SUSPENSION

 

This
Agreement shall be suspended upon any of the following events, and shall remain suspended until such event is rectified:

 

		i.	The
                                            trading of the Common Stock is suspended by the SEC, the Principal Market or FINRA for a
                                            period of two (2) consecutive Trading Days during the Open Period;

 

		ii.	The
                                            Common Stock ceases to be quoted, listed or traded on the Principal Market or the Registration
                                            Statement is no longer effective (except as permitted hereunder);

 

		iii.	The
                                            Company breaches representation, warranty, covenant or other such term;

 

		iv.	The
                                            Company files, threatens or is compelled into Bankruptcy or insolvency; or

 

		v.	The
                                            Common Stock is no longer DWAC eligible.

 

		vi.	Immediately
                                            upon the occurrence of one of the above-described events, the Company shall send written
                                            notice of such event to the Investor.

 

SECTION
X

INDEMNIFICATION

 

In
consideration of the parties mutual obligations set forth in the Transaction Documents, the Company (the “Indemnitor”)
shall defend, protect, indemnify and hold harmless the Investor and all of the investor’s shareholders, officers, directors, employees,
counsel, and direct or indirect investors and any of the foregoing person’s agents or other representatives (including, without
limitation, those retained in connection with the transactions contemplated by this Agreement) (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and reasonable
expenses in connection therewith (irrespective of whether any such Indemnitee is a party to the action for which indemnification hereunder
is sought), and including reasonable attorneys’ fees and disbursements (the “Indemnified Liabilities”), incurred
by any Indemnitee as a result of, or arising out of, or relating to (I) any misrepresentation or breach of any representation or warranty
made by the Indemnitor or any other certificate, instrument or document contemplated hereby or thereby; (II) any breach of any covenant,
agreement or obligation of the Indemnitor contained in the Registered Offering Transaction Documents or any other certificate, instrument
or document contemplated hereby or thereby; or (III) any cause of action, suit or claim brought or made against such Indemnitee by a
third party and arising out of or resulting from the execution, delivery, performance or enforcement of the Registered Offering Transaction
Documents or any other certificate, instrument or document contemplated hereby or thereby, except insofar as any such misrepresentation,
breach or any untrue statement, alleged untrue statement, omission or alleged omission is made in reliance upon and in conformity with
information furnished to Indemnitor which is specifically intended for use in the preparation of any such Registration Statement, preliminary
prospectus, prospectus or amendments to the prospectus. To the extent that the foregoing undertaking by the Indemnitor may be unenforceable
for any reason, the Indemnitor shall make the maximum contribution to the payment and satisfaction of each of the Indemnified Liabilities
which is permissible under applicable law. The indemnity provisions contained herein shall be in addition to any cause of action or similar
rights Indemnitor may have, and any liabilities the Indemnitor or the Indemnitees may be subject to.

 

    18

     

    

 

SECTION
XI

GOVERNING
LAW; DISPUTES SUBMITTED TO ARBITRATION.

 

11.1
Law Governing this Agreement. This Agreement shall be governed by and construed
in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party
against the other concerning the transactions contemplated by this Agreement shall be brought only in the state or federal courts located
in New York City, New York State. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any
action instituted hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens.
The parties executing this Agreement and other agreements referred to herein or delivered in connection herewith on behalf of the
Company agree to submit to the in personam jurisdiction of such courts and hereby irrevocably waive trial by jury. The prevailing
party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that any provision
of this Agreement or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable statute or
rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified
to conform with such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably waives personal service of process
and consents to process being served in any suit, action or proceeding in connection with this Agreement or any other Transaction Documents
by mailing a copy thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address
in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process
and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any other manner permitted
by law.

 

11.2
LEGAL FEES; AND MISCELLANEOUS FEES. At the Closing of the first Put, the Company shall deposit six thousand dollars ($6,000) with
the Investor’s designated legal counsel to offset legal costs. Except as otherwise set forth in the Registered Offering Transaction
Documents (including but not limited to Section V of the Registration Rights Agreement), each party shall pay the fees and expenses of
its advisers, counsel, the accountants and other experts, if any, and all other expenses incurred by such party incident to the negotiation,
preparation, execution, delivery and performance of this Agreement. Any attorneys’ fees and expenses incurred by either the Company
or the Investor in connection with the preparation, negotiation, execution and delivery of any amendments to this Agreement or relating
to the enforcement of the rights of any party, after the occurrence of any breach of the terms of this Agreement by another party or
any default by another party in respect of the transactions contemplated hereunder, shall be paid on demand by the party which breached
the Agreement and/or defaulted, as the case may be. The Company shall pay all stamp and other taxes and duties levied in connection with
the issuance of any Securities.

 

11.3
COUNTERPARTS. This Agreement may be executed in any number of counterparts and by the different signatories hereto on separate
counterparts, each of which, when so executed, shall be deemed an original, but all such counterparts shall constitute but one and the
same instrument. This Agreement may be executed by facsimile transmission, PDF, electronic signature or other similar electronic means
with the same force and effect as if such signature page were an original thereof.

 

    19

     

    

 

11.4
HEADINGS; SINGULAR/PLURAL. The headings of this Agreement are for convenience of reference and shall not form part of, or affect
the interpretation of, this Agreement. Whenever required by the context of this Agreement, the singular shall include the plural and
masculine shall include the feminine.

 

11.5
SEVERABILITY. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability
shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the validity or enforceability
of any provision of this Agreement in any other jurisdiction.

 

11.6
ENTIRE AGREEMENT; AMENDMENTS. This Agreement is the FINAL AGREEMENT between the Company and the Investor with respect to the terms
and conditions set forth herein, and, the terms of this Agreement may not be contradicted by evidence of prior, contemporaneous, or subsequent
oral agreements of the Parties. No provision of this Agreement may be amended other than by an instrument in writing signed by the Company
and the Investor, and no provision hereof may be waived other than by an instrument in writing signed by the party against whom enforcement
is sought. The execution and delivery of the Registered Offering Transaction Documents shall not alter the force and effect of any other
agreements between the Parties, and the obligations under those agreements.

 

11.7
NOTICES. Any notices or other communications required or permitted to be given under the terms of this Agreement must be in writing
and will be deemed to have been delivered (I) upon receipt, when delivered personally; (II) upon receipt, when sent by email; or (III)
one (1) day after deposit with a nationally recognized overnight delivery service, in each case properly addressed to the party to receive
the same. The addresses for such communications shall be:

 

	 	If
                                            to the Company:

     

    
	 	VNUE,
                                 Inc.

    104
    W. 29th Street 11th Floor

    New
York, NY 10001

Attn: Zach Bair, CEO

    

	 	 	 	 
	 	With
a copy to

(which copy shall not

constitute notice):	 	 
	 	 	 	 
	 	If
                                 to the Investor:
	 	GHS
                                 Investments, LLC

    420
    Jericho Turnpike,

    Suite 102

    Jericho, NY 11753

 

Each
party shall provide five (5) days prior written notice to the other party of any change in address.

 

    20

     

    

 

11.8
NO ASSIGNMENT. This Agreement may not be assigned.

 

11.9
NO THIRD PARTY BENEFICIARIES. This Agreement is intended for the benefit of the parties hereto and is not for the benefit of,
nor may any provision hereof be enforced by, any other person, except that the Company acknowledges that the rights of the Investor may
be enforced by its general partner.

 

11.10
SURVIVAL. The representations and warranties of the Company and the Investor contained in Sections 3 and 4, the agreements
and covenants set forth in Sections 5 and 6, and the indemnification provisions set forth in Section 10, shall survive
each of the Closings and the termination of this Agreement.

 

11.11
PUBLICITY. The Investor acknowledges that this Agreement and all or part of the Registered Offering Transaction Documents may
be deemed to be “material contracts” as that term is defined by Item 601(b)(10) of Regulation S-K, and that the Company
may therefore be required to file such documents as exhibits to reports or registration statements filed under the 1933 Act or the 1934
Act. The Investor further agrees that the status of such documents and materials as material contracts shall be determined solely by
the Company, in consultation with its counsel.

 

11.12
FURTHER ASSURANCES. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and
shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

11.13
PLACEMENT AGENT. If so required, the Company agrees to pay a registered broker dealer, to act as placement agent. The Investor
shall have no obligation with respect to any fees or with respect to any claims made by or on behalf of other persons or entities for
fees of a type contemplated in this Section that may be due in connection with the transactions contemplated by the Registered Offering
Transaction Documents. The Company shall indemnify and hold harmless the Investor, their employees, officers, directors, agents, and
partners, and their respective affiliates, from and against all claims, losses, damages, costs (including the costs of preparation and
attorney’s fees) and expenses incurred in respect of any such claimed or existing fees, as such fees and expenses are incurred.

 

11.14
NO STRICT CONSTRUCTION. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party, as the parties mutually agree that each has
had a full and fair opportunity to review this Agreement and seek the advice of counsel on it.

 

11.15
REMEDIES. The Investor shall have all rights and remedies set forth in this Agreement and the Registration Rights Agreement and
all rights and remedies which such holders have been granted at any time under any other agreement or contract and all of the rights
which the Investor has by law. Any person having any rights under any provision of this Agreement shall be entitled to enforce such rights
specifically (without posting a bond or other security), to recover damages by reason of any default or breach of any provision of this
Agreement, including the recovery of reasonable attorneys fees and costs, and to exercise all other rights granted by law.

 

    21

     

    

 

11.16
PAYMENT SET ASIDE. To the extent that the Company makes a payment or payments to the Investor hereunder or under the Registration
Rights Agreement or the Investor enforces or exercises its rights hereunder or thereunder, and such payment or payments or the proceeds
of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside,
recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any
other person under any law (including, without limitation, any bankruptcy law, state or federal law, common law or equitable cause of
action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived
and continued in full force and effect as if such payment had not been made or such enforcement or setoff had not occurred.

 

11.17
PRICING OF COMMON STOCK. For purposes of this Agreement, the price of the Common Stock shall be as reported by Quotestream Media.

 

SECTION
XII

NON-DISCLOSURE
OF NON-PUBLIC INFORMATION

 

The
Company shall not disclose non-public information to the Investor, its advisors, or its representatives.

 

Nothing
herein shall require the Company to disclose non-public information to the Investor or its advisors or representatives, and the Company
represents that it does not disseminate non-public information to any investors who purchase stock in the Company in a public offering,
to money managers or to securities analysts, provided, however, that notwithstanding anything herein to the contrary, the Company will,
as hereinabove provided, immediately notify the advisors and representatives of the Investor and, if any, underwriters, of any event
or the existence of any circumstance (without any obligation to disclose the specific event or circumstance) of which it becomes aware,
constituting non-public information (whether or not requested of the Company specifically or generally during the course of due diligence
by such persons or entities), which, if not disclosed in the prospectus included in the Registration Statement would cause such prospectus
to include a material misstatement or to omit a material fact required to be stated therein in order to make the statements, therein,
in light of the circumstances in which they were made, not misleading. Nothing contained in this Section 12 shall be construed
to mean that such persons or entities other than the Investor (without the written consent of the Investor prior to disclosure of such
information) may not obtain non-public information in the course of conducting due diligence in accordance with the terms of this Agreement
and nothing herein shall prevent any such persons or entities from notifying the Company of their opinion that based on such due diligence
by such persons or entities, that the Registration Statement contains an untrue statement of material fact or omits a material fact required
to be stated in the Registration Statement or necessary to make the statements contained therein, in light of the circumstances in which
they were made, not misleading.

 

SECTION
XIII

ACKNOWLEDGEMENTS
OF THE PARTIES

 

Notwithstanding
anything in this Agreement to the contrary, the parties hereto hereby acknowledge and agree to the following: (i) the Investor makes
no representations or covenants that it will not engage in trading in the securities of the Company, other than as provided in Section 3.12
of this Agreement; (ii) the Company shall, by 8:30 a.m. EST on the fourth Trading Day following the date hereof, file a current report
on Form 8-K disclosing the material terms of the transactions contemplated hereby and in the other Registered Offering Transaction
Documents; (iii) the Company has not and shall not provide material non-public information to the Investor unless prior thereto the Investor
shall have executed a written agreement regarding the confidentiality and use of such information; and (iv) the Company understands and
confirms that the Investor will be relying on the acknowledgements set forth in clauses (i) through (iii) above if the Investor effects
any transactions in the securities of the Company.

 

[Signature
page follows]

 

    22

     

    

 

Your
signature on this Signature Page evidences your agreement to be bound by the terms and conditions of the Investment Agreement as of the
date first written above. The undersigned signatory hereby certifies that he has read and understands the Investment Agreement, and the
representations made by the undersigned in this Investment Agreement are true and accurate, and agrees to be bound by its terms.

 

	 	GHS INVESTMENTS,
    LLC
	 	 
	 	By:	
	 	Name:	
	 	Title:	Member
    
	 	 
	 	VNUE, INC.
	 	 
	 	By: 	
	 	Name: 	Zach Bair
	 	Title:	CEO and Chairman

 

[SIGNATURE PAGE OF EQUITY FINANCING AGREEMENT]

 

    23

     

    

 

LIST
OF EXHIBITS

 

		EXHIBIT
                            A	Registration
                                         Rights Agreement

 

		EXHIBIT
                            B	Notice
                                         of Effectiveness

 

		EXHIBIT
                            C	Put
                                         Notice

 

		EXHIBIT
                            D	Put
                                         Settlement Sheet

 

    24

     

    

 

EXHIBIT
A

 

REGISTRATION
RIGHTS AGREEMENT

 

See
attached.

 

    A-1

     

    

 

EXHIBIT
B

 

FORM
OF NOTICE OF EFFECTIVENESS

OF REGISTRATION STATEMENT

 

		Date:	

 

[TRANSFER
AGENT]

 

		Re:	VNUE,
                                            Inc.

 

Ladies
and Gentlemen:

 

We
are counsel to VNUE, Inc., a Nevada corporation (the “Company”), and have represented the Company in connection with that
certain Equity Financing Agreement (the “Investment Agreement”) entered into by and among the Company and GHS Investments,
LLC(the “Investor”) pursuant to which the Company has agreed to issue to the Investor shares of the Company’s common
stock, $_____ par value per share (the “Common Stock”) on the terms and conditions set forth in the Investment Agreement.
Pursuant to the Investment Agreement, the Company also has entered into a Registration Rights Agreement with the Investor (the “Registration
Rights Agreement”) pursuant to which the Company agreed, among other things, to register the Registrable Securities (as defined
in the Registration Rights Agreement), including the shares of Common Stock issued or issuable under the Investment Agreement under the
Securities Act of 1933, as amended (the “1933 Act”). In connection with the Company’s obligations under the Registration
Rights Agreement, on ____________ ___, 20__, the Company filed a Registration Statement on Form S-1 (File No. __-________) (the “Registration
Statement”) with the Securities and Exchange Commission (the “SEC”) relating to the Registrable Securities which names
the Investor as a selling shareholder thereunder.

 

In
connection with the foregoing, we advise you that a member of the SEC’s staff has advised us by telephone that the SEC has entered
an order declaring the Registration Statement effective under the 1933 Act at ______ on __________, 20__ and we have no knowledge, after
telephonic inquiry of a member of the SEC’s staff, that any stop order suspending its effectiveness has been issued or that any
proceedings for that purpose are pending before, or threatened by, the SEC and the Registrable Securities are available for sale under
the 1933 Act pursuant to the Registration Statement

 

			Very
                                            truly yours,

 

			[Company
                                            Counsel]

 

    B-1

     

    

 

EXHIBIT
C

 

FORM
OF PUT NOTICE

 

Date:

 

		RE:	Put
                                            Notice Number __

 

Dear
Mr./Ms.__________,

 

This
is to inform you that as of today, VNUE, Inc., a Nevada corporation (the “Company”), hereby elects to exercise its right
pursuant to the Equity Financing Agreement to require GHS Investments LLC to purchase shares of its common stock. The Company hereby
certifies that:

 

The
amount of this put is $ _______________.

 

The
Pricing Period runs from _______________ until _______________.

 

The
Purchase Price is: $ _______________

 

The
number of Put Shares due: _______________.

 

The
current number of shares of common stock issued and outstanding is: _______________.

 

The
number of shares currently available for issuance on the S-1 is: _______________.

 

Regards,

 

VNUE,
Inc.

 

	By:		 
	Name: 	 	 
	Title:	 	 

 

    C-1

     

    

 

EXHIBIT
D

 

PUT
SETTLEMENT SHEET

 

Date:
________________

 

Dear
Mr. ________,

 

Pursuant
to the Put given by VNUE, Inc., to GHS Investments LLC (“GHS”) on _________________ 202_, we are now submitting the amount
of common shares for you to issue to GHS.

 

Please
have a certificate bearing no restrictive legend totaling __________ shares issued to GHS immediately and send via DWAC to the following
account:

 

[INSERT]

 

If
not DWAC eligible, please send FedEx Priority Overnight to:

 

[INSERT
ADDRESS]

 

Once
these shares are received by us, we will have the funds wired to the Company.

 

Regards,

 

GHS
INVESTMENTS LLC

 

	By:		 
	Name: 	 	 
	Title:	 	 

 

    D-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00345-of-00352.parquet"}]]